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ABSTRACT
Singleton pregnancies achieved by means of  
assisted reproductive treatment (ART) are 
associated with increased obstetric and neonatal 
risks in comparison with spontaneously 
conceived singleton pregnancies. The impact of  
infertility- and treatment-related factors on these 
risks is not properly understood. In addition, 
the psychological effects of  infertility and its 
treatment on the experience of  pregnancy have 
scarcely been studied. Thus, the aim of  the 
present study was to evaluate the importance 
of  infertility- and treatment-related factors on 
prediction of  pregnancy outcome, obstetric and 
neonatal risks, fear-of-childbirth and pregnancy-
related anxiety.
The subjects consisted of  three different 
cohorts of  infertile women who achieved 
a singleton pregnancy by means of  in vitro 
fertilisation (IVF) or intracytoplasmic sperm 
injection (ICSI) at the Infertility Clinics of  
Helsinki University Central Hospital, The Family 
Federation of  Finland and The Deaconess 
Institute. The control groups comprised 
spontaneously conceiving women with singleton 
gestations. Early pregnancy outcome was 
assessed by means of  assay of  serum human 
chorionic gonadoptrophin (hCG) in single 
samples. Other outcome data were collected 
from patient records, national Health Registers 
and via prospective questionnaire surveys. 
Viable pregnancies were associated 
with signifi cantly higher serum hCG levels 12 
days after embryo transfer than non-viable 
pregnancies. Among singleton pregnancies, 
aetiological subgroup, treatment type or the 
number of  transferred embryos did not impair 
the predictive value of  single hCG assessment.
According to the register-based data, 
age-, parity- and socioeconomic status- adjusted 
risks of  gestational hypertension, preterm 
contractions and placenta praevia were more 
frequent in the ART pregnancies than in the 
control pregnancies. Signifi cantly higher rates 
of  induction of  delivery and Caesarean section 
occurred in the ART group than in the control 
group. The risks of  preterm birth and low 
birth weight (LBW) were increased after ART 
pregnancy. Duration or aetiology of  infertility, 
treatment type (fresh or frozen IVF or ICSI) 
or rank of  treatment did not contribute to the 
risks of  preterm birth or LBW.  In addition, 
the risks of  preterm birth and LBW remained 
elevated regardless of  the number of  transferred 
embryos. Although mean duration of  pregnancy 
was shorter and mean birth weight lower 
in the ART pregnancies than in the control 
pregnancies, these differences were hardly of  
clinical signifi cance.
Fear-of-childbirth and pregnancy-
related anxiety were equally common to women 
conceiving by means of  ART, or spontaneously. 
Partnership of  fi ve to ten years appeared to be 
protective as regards severe fear-of-childbirth, 
whereas long preceding infertility (≥ seven 
years) had the opposite effect. 
In conclusion, no specifi c infertility- 
or patient-related factor that would alter the 
predictive value of  an early hCG assessment 
could be identifi ed. Neither did we recognise 
any infertility- or patient-related factors that 
would expose infertile women to increased 
obstetric or neonatal risks. However, a long 
period of  infertility was associated with severe 
fear-of-childbirth. These fi ndings suggest that 
the reasons for increased obstetric and neonatal 
risks in singleton gestation after ART should be 
sought among underlying factors other than the 
clinical factors involved in this study.
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INTRODUCTION
One in six couples suffers from infertility some 
time during their life. Infertility is considered 
a major life-crisis and feelings of  grief, anxiety 
and depression are common.
Infertility can be effi ciently treated by 
means of  ART. Since the introduction of  IVF 
in 1978 approximately two million infants 
worldwide have been born with the aid of  
different ART modalities. In 2004, 2.7% of  all 
Finnish infants were born after ART.
As early as in the fi rst pregnancy outcome 
reports in the 1980s, signifi cantly more obstetric 
and neonatal complications in ART pregnancies 
than in spontaneously conceived control 
pregnancies were documented. To a great extent 
this was the result of  a nearly 20-fold higher 
rate of  multiple gestations (~25%) in ART 
pregnancy cohorts than in cohorts following 
spontaneous conception. Although the high rate 
of  multiple pregnancies can be prevented with 
single embryo transfer, all the observed adverse 
pregnancy outcomes may not. Indeed, singleton 
pregnancies after ART are associated with 
increased risks of  ectopic pregnancy, abnormal 
placentation, Caesarean section, preterm birth, 
neonatal mortality and congenital malformations 
compared with age- and parity-matched control 
pregnancies. 
Better understanding of  the underlying 
mechanisms behind adverse pregnancy 
outcomes in singleton pregnancies after ART is 
crucial for patient counselling, performing ART 
and for clinically following these pregnancies. 
Furthermore, more pronounced anxiety over 
loss of  pregnancy after ART may negatively 
affect the experience of  pregnancy and lay 
grounds for fear-of-childbirth. The present 
study was designed to evaluate infertility- and 
treatment-related factors in relation to early 
pregnancy monitoring, obstetric and neonatal 
complications and prevalence of  fear-of-
childbirth and pregnancy-related anxiety.
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REVIEW OF THE LITERATURE
Infertility
The failure to conceive after a year of  unprotected 
timed intercourse is referred to as infertility in 
medical literature (Tietze 1968; Evers 2002). 
The incidence of  infertility is highly dependent 
on female age and varies from six per cent in 
the age group of  women under 25 years to 15–
35% in women after their thirties (Menken et al. 
1986; Baird et al. 2005). The lifetime incidence 
of  infertility is estimated to lie between 10 to 
17% (Hull et al. 1985; Snick et al. 1997). Also, 
according to a recent Finnish health survey, 
14.4% of  all female participants and 17.6% of  
women aged 20–54 years had experienced a 
period of  involuntary childlessness sometime 
during their lives (Health 2000 2004).
Possible changes in the incidence of  
infertility over time are diffi cult to assess because 
of  contraceptive use, delay in the attempt to 
become pregnant, and timing of  pregnancies. 
However, population-based surveys indicate that 
infertility has decreased rather than increased in 
the past four decades (Akre et al. 1999; Joffe 
2000; Stephen and Chandra 2006).
Aetiology of  infertility
The aetiology of  infertility is categorised as 
female in 25–47% of  cases, male in 16–26%, 
combined in 18% and unexplained in 12–30% 
(Hull et al. 1985; Evers 2002; Wright et al. 2006). 
The main subgroups of  female infertility can 
be further defi ned as tubal factor (24% of  all 
female causes), ovulatory dysfunction (34%), 
endometriosis (11%) and other (31%) (Figure 
1) (Wright et al. 2006). The distribution of  
different aetiological subgroups in cases of  
female infertility shows demographic and global 
variation and corresponds to the conditions that 
lead to infertility. In the developed world, an 
overweight condition, smoking and increased 
female age at the time of  pregnancy attempts 
are related to a higher incidence of  ovulatory 
dysfunction, whereas in parts of  the developing 
world pelvic infl ammatory disease is relatively 
common and increases the rate of  tubal factor 
infertility (Cates et al. 1985).
The aetiology of  male infertility is less 
well understood. In nearly 50% of  infertile men 
no single cause of  infertility can be identifi ed 
(Iammarrone et al. 2003). In the rest, impaired 
sperm production and function may be related to 
hypogonadotrophic hypognadism, chromosomal 
or genetic disorders, cryptorchidism (failure of  
the testes to descend), cancer and its treatment, 
drugs and environmental toxins (Skakkebaek et 
al. 1994). In addition, sperm transport can be 
disturbed as a result of  testicular obstruction 
(following vasectomy, infections or absence 
of  the vas deferens), retrograde ejaculation or 
impotence.
The classifi cation of  different forms 
of  male factor infertility is based on sperm 
concentration and morphology. Semen quality 
has been suggested to have deteriorated in the 
past century (Carlsen et al. 1992; Andersen et 
al. 2000; Aitken et al. 2004), which might be 
one manifestation of  disturbed fetal testicular 
development and testicular dysgenesis syndrome 
(Bay et al. 2006). Nevertheless, abnormal semen 
values do not easily discriminate an infertile man 
from a fertile one (Guzick et al. 2001).
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Figure 1. Percentage distribution of  different aetiological subgroups among 74 296 infertile couples 
who received fresh embryo transfers in the USA in 2003 (Wright et al. 2006). 
The subgroup “other female” includes cases with uterine factor or multiple, female-related factors.
The subgroup “other” includes cases with immunological problems or chromosomal abnormalities, cancer 
chemotherapy, or serious illnesses. 
Tubal
11 %
Ovulatory
dysfunction
16 %
Endometriosis
5 %
Other female
15 %Male
16 %
Combined
17 %
Unexplained
12 %
Other
8 %
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Assisted reproductive treatment (ART)
The fi rst infant following transfer of  an 
oocyte fertilized in vitro was born in 1978 
(Steptoe and Edwards 1978). Initially, IVF was 
developed to overcome tubal factor infertility. 
Later on, achievements in treatment of  other 
female-related infertility subgroups and the 
introduction of  ICSI for male factor infertility 
in 1992 (Palermo et al. 1992) have broadened 
the indications for ART.
Controlled ovarian stimulation 
Assisted reproductive treatment was initially 
performed in a natural cycle with single embryo 
transfer (Steptoe and Edwards 1978). Transfer of  
a single embryo yielded only moderate results and 
therefore controlled ovarian stimulation (COS) 
was developed in order to achieve numerous 
oocytes to be fertilized and transferred. The use 
of  gonadotrophin-releasing hormone (GnRH) 
agonists for reversible pituitary down-regulation 
in combination with exogenous gonadotrophin 
stimulation was introduced in the 1980s (Fleming 
et al. 1982; Porter et al. 1984) and has remained 
the most widely used COS protocol. Antagonists 
of  GnRH have also been an option in COS since 
the late 1990s (Borm and Mannaerts 2000).
Treatment with GnRH agonists usually 
starts in the mid-luteal phase of  the preceding 
menstrual cycle, with leuprolide acetate, nafarelin 
acetate, buserelin or triptorelin (Simberg et al. 
1998). Most commonly, recombinant follicle-
stimulating hormone (rFSH) is used as an 
exogenous gonadotrophin (Tulppala et al. 1999). 
Ovarian stimulation is monitored by means 
of  (serial) serum estradiol (E2) measurements 
and transvaginal sonography (TVS). When at 
least two follicles reach a diameter of  17 mm 
in TVS, exogenous hCG is administered to 
complete follicular maturation. Oocyte retrieval 
is performed (with TVS guidance) 34–36 hours 
after hCG administration.
Semen collection and fertilization of  oocytes
In conventional IVF, semen is collected by 
means of  masturbation. In cases of  severe 
male factor infertility semen can be obtained 
by epididymal or testicular sperm aspiration or 
from the urinary bladder. The semen sample 
is subjected to a “swim-up” procedure and 
centrifugation in order to obtain motile sperm 
for insemination. The retrieved oocytes are 
inseminated with sperm approximately four 
hours after retrieval. An oocyte can also be 
fertilized with a single sperm, as in ICSI. This is 
the treatment of  choice in male factor infertility, 
in cases of  surgically retrieved sperm or in cases 
of  previous fertilization failure in conventional 
IVF cycles.
Approximately 50–70% of  inseminated/
injected oocytes are fertilized in an IVF/ICSI 
cycle. Fertilization is assessed after approximately 
18 hours of  incubation (i.e. on the fi rst day after 
retrieval). Fertilization has occurred when two 
polar bodies and two (female and male) pronuclei 
can be visualized under a light microscope. After 
fertilization the pronuclear membranes break 
down, a diploid number of  chromosomes is 
achieved and the fi rst cell division is possible.
Embryo selection and transfer
Morphological criteria
The development of  an embryo follows a distinct 
pattern of  events: the zygotes start to divide 
approximately 25–27 hours after insemination, 
i.e. on day one (D1) (Balakier et al. 1993), a four 
cell stage can be reached on day 2 (D2) and a 
blastocyst stage on day fi ve (D5).
Numerous morphological features of  
cleavage-stage embryos have been used to 
distinguish the best implanting embryos. The 
early cleavage rate (Shoukir et al. 1997; Sakkas 
et al. 1998; Lundin et al. 2001; Salumets et al. 
2003a), number of  blastomeres as regards the 
day of  embryo development (Van Royen et 
al. 1999), blastomere fragmentation (Antczak 
and Van Blerkom 1999), and presence of  
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multinucleated blastomeres have all been found 
to be predictive of  both implantation and 
pregnancy rates (Jackson et al. 1998; Hardarson 
et al. 2001). Ideally, a four-cell embryo on D2 or 
an eight-cell embryo on D3 with less than 20% 
fragmentation, equal blastomere size and without 
multinucleated blastomeres is transferred. 
Number of  transferred embryos
For as long as the recognition of  embryos with 
the best implantation potential had not been 
settled, the only option to improve pregnancy 
rates was to increase the number of  transferred 
embryos (Testart et al. 1986). Transfer of  three to 
four embryos at the same time became standard, 
but at the price of  increasing the numbers of  
triplet and quadruplet pregnancies. However, by 
the mid 1990s it had become evident that limiting 
the number of  transferred embryos to two 
instead of  three maintained the pregnancy rates 
but signifi cantly decreased the rate of  triplet and 
higher-order pregnancies (Staessen et al. 1993; 
Templeton and Morris 1998). At the end of  the 
1990s elective single embryo transfer (eSET) 
was introduced (Gerris et al. 1999; Vilska et al. 
1999). Elective single embryo transfer refers to 
a procedure where a single embryo is selected 
from a pool of  embryos and the rest are frozen. 
Currently, 46% of  Finnish ART cycles are 
performed with single embryo transfer (SET) 
(STAKES 2006). The corresponding fi gure for 
the whole of  Europe in 2002 was 13.7% (The 
European IVF-monitoring programme (EIM), 
2006) and in the United States in 2003 it was 
10.2% (Wright et al. 2006).
Cryopreservation and thawing of  embryos
The fi rst human pregnancy after cryopreservation 
and thawing of  an embryo was reported in 
1983 (Trounson and Mohr 1983). Thereafter, 
cryopreservation became an essential part 
of  ART. The main advantages of  embryo 
cryopreservation are the possibility to perform 
embryo transfer with fewer embryos at a time but 
with several embryos altogether, the prevention 
of  exacerbation of  ovarian hyperstimulation 
syndrome (OHSS) by postponing embryo 
transfer to a later cycle, and possible preservation 
of  fertility for future purposes. 
Human embryos can be frozen and 
thawed from the pronuclear to the blastocyst 
stage (Michelmann and Nayudu 2006). In 
general, freezing and thawing is associated with 
a 70–80% survival rate of  blastomeres (Edgar et 
al. 2000). Frozen embryo transfer (FET) can be 
performed in natural or hormonally substituted 
cycles. Regardless of  the type of  cycle, 
synchronisation of  the stages of  development 
of  frozen-thawed embryos and the endometrium 
is important. The timing of  embryo transfer is 
carried out by assessing the luteinizing hormone 
(LH) surge in a natural cycle and by evaluating 
the appearance of  the endometrium in TVS in a 
hormonally substituted cycle.
Recently, the concept of  elective transfer 
of  single embryos has also been applied in 
frozen-thawed ART cycles (Hyden-Granskog et 
al. 2005).
Treatment outcomes after ART
In Europe in 2002, the clinical pregnancy rates 
per embryo transfer were 29.5% (IVF), 29.4% 
(ICSI) and 18.4% (FET) (The European IVF-
monitoring programme (EIM), 2006). The 
pregnancy rate remains similar in the fi rst three 
ART cycles (Templeton et al. 1996) but the 
cumulative pregnancy rate plateaus by the sixth 
cycle to a level of  55% to 66% (Dor et al. 1996; 
Stolwijk et al. 2000; Hoveyda et al. 2002; Olivius 
et al. 2002; Witsenburg et al. 2005). In Finland 
in 1992–2004, the clinical pregnancy rates per 
embryo transfer were 28.4% (IVF), 28.1% 
(ICSI) and 19.3% (FET) (STAKES 2006). 
The pregnancy rates after ART are 
dependent on several subject- and treatment-
related characteristics. Therefore, great variation 
both in national and international fi gures exists 
and comparison of  pregnancy rates without 
clinical details gives only a restricted picture. 
The most important prognostic factors, such 
as female age, weight, smoking, and number 
and quality of  embryos infl uence the rate 
of  both non-viable and viable pregnancies – 
understandably in opposite directions.
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Prognostic factors
The most important prognostic factor of  an 
ongoing pregnancy after ART is female age: 
women under 36 are most likely to achieve a 
pregnancy after ART (Templeton et al. 1996; 
Stolwijk et al. 2000; Olivius et al. 2002; Sharma 
et al. 2002; Witsenburg et al. 2005). On the 
other hand, increasing female age elevates the 
probability of  miscarriage – most markedly 
after the age of  35 years (Gray and Wu 2000; 
Nybo Andersen et al. 2000; Schieve et al. 2003; 
Spandorfer et al. 2004a). The impact of  paternal 
age is less evident, but male age ≥ 40 years has 
been suggested to decrease the ongoing pregnancy 
rates and to increase the rate of  miscarriages (de 
la Rochebrochard and Thonneau 2002; de la 
Rochebrochard et al. 2006).
A woman’s exposure to tobacco smoke 
sometime during her life (Klonoff-Cohen et al. 
2001), and especially in association with ART, 
decreases her chances of  achieving an ongoing 
pregnancy (Augood et al. 1998) and delivering 
an infant (Lintsen et al. 2005). In addition, her 
partner’s smoking and passive smoking are 
deleterious as regards female fertility (Lintsen 
et al. 2005) and success in ART (Zitzmann et 
al. 2003; Neal et al. 2005). Fewer retrieved (El-
Nemr et al. 1998; Klonoff-Cohen et al. 2001; 
Zitzmann et al. 2003), mature (Zenzes et al. 1997) 
and fertilized oocytes in female smokers than 
in non-smoking women undergoing ART are 
observed. Although male smoking is associated 
with worse morphology of  sperm and reduction 
in sperm motility (Kunzle et al. 2003) the impact 
of  male smoking on pregnancy rates after ART 
is less evident than that of  female smoking and 
may be mediated through passive smoking of  
the female spouse.
The results of  studies on the effect 
of  alcohol consumption on fertility are 
heterogeneous. Whereas some state that 
increasing female alcohol consumption decreases 
the odds of  achieving a pregnancy (Jensen et al. 
1998), others have not found an association (Juhl 
et al. 2001). As regards alcohol consumption 
and pregnancy rates after ART, both female and 
male alcohol consumption close to ART seem 
to decrease the chance of  achieving a pregnancy 
(Klonoff-Cohen et al. 2003).
Both underweight and overweight may 
impair fertility in otherwise healthy women. 
In ART, overweight and obese women (body 
mass index [BMI] > 25 kg/m2 and > 30 kg/
m2, respectively) require higher gonadotrophin 
doses (Dodson et al. 2006; Dokras et al. 2006) 
and produce fewer oocytes (Spandorfer et al. 
2004b) than women of  normal weight. Their 
cancellation rate per cycle is higher (Dokras et 
al. 2006) and miscarriages more frequent (Wang 
et al. 2002a; Fedorcsak et al. 2004) than in lean 
women. Consequently, pregnancy and delivery 
rates are lower in overweight and obese women 
than in women of  normal weight (Lintsen et al. 
2005; Dokras et al. 2006). Increased male BMI 
has been suggested to correlating negatively 
with number of  motile sperm (Kort et al. 2006). 
Both low (< 20 kg/m2) and high (> 25kg/
m2) BMI correlate with a reduction in sperm 
concentration (Jensen et al. 2004; Fejes et al. 
2006). Nevertheless, the impact of  male body 
weight on pregnancy rates after ART is not 
documented.
Duration of  infertility plays a marginal 
role in pregnancy rates after ART and is usually 
confounded by increased female age. Each 
additional year of  infertility decreases the odds 
of  a birth by two per cent after maternal age, 
aetiology of  infertility, number of  previous 
ART attempts and number of  fertilized and 
transferred embryos have been taken into account 
(Templeton et al. 1996). Couples with less than 
four years of  infertility have been proposed to 
stand a better chance of  achieving a pregnancy 
after ART (Templeton et al. 1996), but this was 
not confi rmed in another, although smaller, 
study (Stolwijk et al. 2000). A prolonged time 
to achieve a pregnancy (i.e. 12 months or more) 
has been associated with a moderately increased 
risk of  miscarriage (Joffe and Li 1994; Gray and 
Wu 2000; Axmon and Hagmar 2005), but the 
impact of  duration of  infertility on miscarriage 
rates after ART has not been studied.
The signifi cance of  different aetiological 
infertility subgroups on pregnancy rates is 
controversial. According to the largest published 
study, women with tubal factor infertility stand 
a decreased chance (by 30%) of  achieving a 
viable pregnancy compared with women with 
other aetiologies of  infertility (Templeton et al. 
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1996). Women with tubal factor infertility also 
have a higher incidence of  ectopic pregnancies 
(Dubuisson et al. 1991; Karande et al. 1991; 
Ribic-Pucelj et al. 1995; Strandell et al. 1999). 
Women with diminished ovarian reserves also 
tend to have lower than average pregnancy rates 
(Wright et al. 2006). In respect to the risk of  
miscarriage after ART, male factor infertility and 
endometriosis-related infertility are suggested to 
lower this risk (Schieve et al. 2003; Lintsen et al. 
2005), whereas increased risks in women with 
polycystic ovary syndrome (Balen et al. 1993; 
Wang et al. 2001) and unexplained infertility 
(Balen et al. 1993; Wang et al. 2001; Omland et 
al. 2005) have been proposed.
Previous pregnancy and live birth 
– especially if  achieved by means of  ART – 
increases the possibility of  achieving a pregnancy 
after ART (Tan et al. 1994; Alsalili et al. 1995; 
Templeton et al. 1996; Stolwijk et al. 2000). 
Increased numbers of  retrieved (≥ 
5; [Sharma et al. 2002]) and fertilized (≥ 4; 
[Templeton et al. 1996]) oocytes improve the 
pregnancy rates, as does an increased number of  
available embryos (≥ 5) for transfer (Hoveyda et 
al. 2002).
The quality of  transferred embryos is 
also of  great importance as regards pregnancy 
rates. Transfer of  an early cleaving embryo 
(corresponding to a two-cell stage 25–27 hours 
after insemination) results in a nearly twofold 
higher pregnancy rate than transfer of  a later 
cleaving embryo (Shoukir et al. 1997; Sakkas et 
al. 1998; Lundin et al. 2001). Early cleaving has a 
similar impact both in multiple embryo (Shoukir 
et al. 1997; Sakkas et al. 1998; Lundin et al. 2001) 
and in single embryo transfers (Salumets et al. 
2003a). Nevertheless, it seems that early cleavage 
might not bear an independent positive impact 
on pregnancy rate; rather, it coexists with more 
signifi cant predictors – female age and the total 
number of  good quality embryos (Lundin et al. 
2001).
Embryo cleavage during the subsequent 
days in embryo culture also plays a role. Four 
blastomeres on D2 and eight on D3 are associated 
with better ongoing pregnancy rates than other 
numbers of  blastomeres per embryo (Van Royen 
et al. 1999). Further, embryos with no or less than 
20% fragmentation (Giorgetti et al. 1995; Ziebe 
et al. 1997; Van Royen et al. 1999), with equal-
sized blastomeres and without multinucleated 
blastomeres (Jackson et al. 1998; Hardarson et 
al. 2001) are associated with improved ongoing 
pregnancy rates. The implantation and clinical 
pregnancy rates do not seem to correlate strongly 
with the developmental stage of  frozen-thawed 
embryos (Salumets et al. 2003b). However, the 
number of  intact blastomeres (> 50%) and the 
presence of  embryo cleavage are associated with 
improved implantation and clinical pregnancy 
rates (Guerif  et al. 2002; Tang et al. 2006).
No difference in clinical pregnancy rate 
between transfers of  D2 versus D3 cleavage 
stage embryos is evident (Blake et al. 2005). 
Both improved (Papanikolaou et al. 2006) and 
similar (Blake et al. 2005) pregnancy rates after 
transfer of  blastocyst stage versus cleavage stage 
embryos have been reported. Transfer of  three 
or more embryos at a time does not increase 
the chance of  pregnancy over the transfer of  
two embryos, but it increases the number of  
multiple gestations (Templeton and Morris 
1998). Double embryo transfer (DET) results in 
higher pregnancy and live birth rates than SET 
(Pandian et al. 2005). Nevertheless, when fresh 
SET is followed by a subsequent frozen embryo 
transfer cycle, similar live birth rates between 
SET and DET have been observed (Thurin et 
al. 2004; Pandian et al. 2005). 
In vitro fertilization and ICSI are associated 
with similar pregnancy and live birth rates, but 
FET is associated with lower pregnancy and live 
birth rates than fresh embryo transfer cycles (La 
Sala et al. 2004; STAKES 2006; The European 
IVF-monitoring programme (EIM) 2006; Wright 
et al. 2006). The lower live birth rate after FET 
is partly a consequence of  a higher miscarriage 
rate after FET than after fresh embryo transfer 
(STAKES 2006). 
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Outcome of  clinical pregnancies
According to Finnish statistics, approximately one third of  embryo transfers results in a clinical 
pregnancy (STAKES, 2006). Out of  these clinically confi rmed pregnancies 74.4% lead to live birth, 
20.2% to miscarriage, 3% to ectopic pregnancy, 0.4% to induced abortion and 0.5% to stillbirth 
(Figure 2).
Figure 2. Outcomes of  clinical pregnancies (n=17 834) after ART in Finland, 1992–2004 (STAKES 
2006). 
0
10
20
30
40
50
60
70
80
Live birth 74,4 76,4 75,5 70,0
Miscarriage 20,2 18,6 20,2 22,8
Ectopic
pregnancy
3,0 3,2 2,3 3,2
Induced
abortion
0,4 0,5 0,4 0,4
Stillbirth 0,5 0,4 0,5 0,5
Missing 1,5 0,6 1,3 2,9
% % % %
All IVF ICSI FET
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Miscarriage
Miscarriage is fairly common in human 
gestation. Depending on the criteria and study 
methodology 10–20% of  all clinical pregnancies 
end in miscarriage (Abma et al. 1997; Nybo 
Andersen et al. 2000; Speroff  and Fritz 2005).
The incidence of  miscarriage after 
clinically confi rmed ART pregnancy is similar (i.e. 
17–20%) to that after spontaneous conception 
and is higher in singleton than in multiple 
gestations (Schieve et al. 2003; Tummers et al. 
2003; Spandorfer et al. 2004a; The European 
IVF-monitoring programme (EIM), 2006).
The frequency of  miscarriages in 
singleton ART pregnancies achieved by means 
of  eSET varies from 10.9% to 20.5% in fresh 
cycles (Gerris et al. 2002; Thurin et al. 2004; 
STAKES 2006).
Ectopic pregnancy
In an ectopic pregnancy a gestational sac lies 
outside the uterine cavity, most often in the 
ampullary part of  the Fallopian tubes. In cases 
in which both extrauterine and intrauterine 
gestations exist, the pregnancy is defi ned as 
heterotopic. Both ectopic and heterotopic 
pregnancies can cause serious morbidity and 
further impairment of  fertility.
The worldwide incidence of  ectopic 
pregnancy is 1–2%. In Finland the incidence 
of  ectopic pregnancy after ART is around 3% 
(Figure 2) and a twofold increase in the risk of  
ectopic pregnancy in international studies has 
been reported (Cohen et al. 1986; FIVNAT 
[French In Vitro National] 1995; Marcus and 
Brinsden 1995a; Strandell et al. 1999). However, 
the incidence of  ectopic pregnancy rises from 
5.4% to 11.1% in women with tubal factor 
infertility (Dubuisson et al. 1991; Ribic-Pucelj et 
al. 1995; Strandell et al. 1999).
The incidence of  heterotopic pregnancy 
after ART has been approximately 1 per 100 
(Svare et al. 1993; Marcus et al. 1995b; Tal 
et al. 1996) but it has decreased in the past 
decade. Controlled ovarian stimulation, multiple 
embryo transfer and pre-existing tubal damage 
predispose women to heterotopic pregnancies.
Human chorionic gonadotrophin (hCG) 
monitoring
Monitoring the outcome of  a clinically 
confi rmed pregnancy after ART by means of  
TVS is common. The purpose is to confi rm the 
location and viability of  pregnancy. In cases of  
multiple gestation, early TVS also confi rms the 
number of  gestational sacs and determines the 
zygosity. A gestational sac can be visualized at 
the fi fth week of  gestation and fetal heart beat 
at the seventh in viable pregnancies. However, 
the possible complications of  ectopic pregnancy 
develop in earlier gestational weeks. In order to 
detect an ectopic pregnancy before diagnosis 
by means of  TVS is feasible, other monitoring 
methods are required.
Human chorionic gonadotrophin 
is a glycoprotein that consists of  non-
covalently linked α and β subunits. During 
pregnancy, placental hCG is synthesized in 
syncytiotrophoblasts. The production and 
secretion of  hCG in syncytiotrophoblasts is 
regulated by GnRH, growth factors, sex steroids 
and cytokines (Speroff  and Fritz 2005). The 
function of  placental hCG is to take part in 
the maintenance of  pregnancy by stimulating 
progesterone production in the corpus luteum 
in early gestation.
In vitro, transcription of  the hCG gene 
can fi rst be detected in embryos at the eight-cell 
stage (Bonduelle et al. 1988). In a culture media, 
hCG can be detected seven to eight days after 
fertilization (Hay and Lopata 1988; Lopata and 
Hay 1989). In vivo, hCG fi rst appears in maternal 
serum seven to ten days after fertilization 
(Marshall et al. 1968; Braunstein et al. 1973; 
Lenton et al. 1982; Stenman et al. 1997). After 
COS, maternal serum hCG is fi rst detectable 
seven to nine days after embryo transfer (Lopata 
et al. 1982; Alfthan et al. 1988; Hsu et al. 1998). 
Exogenous hCG used for oocyte maturation 
before oocyte retrieval results in a peak of  
serum hCG one day after injection, with baseline 
values again reached within eight to thirteen days 
(Stenman et al. 1997).
Maternal serum concentrations of  
hCG rise exponentially in early pregnancy. The 
doubling time of  hCG in viable pregnancies 
increases with increasing gestational age 
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(Pittaway et al. 1985; Check et al. 1992). The 
doubling times in viable pregnancies following 
spontaneous conception and ART are similar. 
Measurement of  maternal urinary or 
serum hCG has proven to be a reliable tool for 
early confi rmation of  pregnancy. With most 
current pregnancy test kits, 98% of  samples will 
be positive seven days after implantation, i.e. at 
the time of  missed menses (Chard 1992). A single 
serum hCG measurement has also shown the 
best discriminatory potential among commonly 
used biochemical markers in predicting the 
outcome of  ART (Lower and Yovich 1992) 
and has been widely accepted for monitoring 
early pregnancy after ART (Table 1). Prediction 
of  pregnancy after ART by means of  a single 
hCG assessment can be done with suffi cient 
reliability eleven to twelve days after ET (Lenton 
et al. 1982; Lopata et al. 1982; Legro et al. 1995). 
Generally, viable pregnancies are associated with 
higher hCG levels and a shorter doubling time 
than non-viable pregnancies (Confi no et al. 1986; 
Okamoto et al. 1987; Schmidt et al. 1994; Bjercke 
et al. 1999; Chung et al. 2006). Further, multiple 
gestations show higher levels of  maternal serum 
hCG than singleton gestations. In non-viable 
pregnancies, the lowest hCG levels are shown 
in biochemical pregnancies. In fi rst trimester 
miscarriages and in ectopic pregnancies, initial 
hCG levels are lower than in viable pregnancies, 
but signifi cant overlapping with the hCG levels 
of  viable pregnancies may occur. In ectopic 
pregnancies, implantation of  a blastocyst occurs 
later than in intrauterine pregnancies, thus 
resulting in a later rise of  hCG than in viable 
pregnancies (Korhonen et al. 1996; Sugantha 
et al. 2000). Nevertheless, the doubling time of  
hCG concentrations in ectopic pregnancies is 
similar to that in viable singleton pregnancies 
(Korhonen et al. 1996; Sugantha et al. 2000) and 
serial hCG sampling may be needed.
Different ART protocols may have 
a different impact on a single hCG level. 
Treatment with GnRH agonists has been 
suggested to be associated with a slower initial 
rise but with a similar doubling time of  serum 
hCG concentrations compared with ovarian 
stimulation without GnRH agonists (Tur-Kaspa 
et al. 1990; Ertzeid et al. 2000). In addition, the 
treatment type and the aetiology of  infertility 
may be related to differences in “early” hCG 
levels in viable ART pregnancies. Gold and 
colleagues (2000) reported that hCG levels 
were higher in cases with tubal factor infertility 
than in those with male factor and unexplained 
infertility. Further, in a small subgroup of  women 
with unexplained infertility, lower hCG values 
were observed 16 days after embryo transfer in 
pregnancies following ICSI than in pregnancies 
following IVF (Gold et al. 2000). 
The impact of  the number of  transferred 
embryos on the discriminatory value of  early 
hCG levels in singleton ART pregnancies has 
not been thoroughly studied. A single study 
involved assay of  hCG values 12 days after SET 
and it was found that an hCG-β cut-off  value 
of  ≥ 45 IU/L had 75.6% sensitivity and 100% 
specifi city for predicting viable pregnancy (De 
Neubourg et al. 2004). 
Serum hCG concentrations are different 
in ART pregnancies than in spontaneous 
pregnancies at the time of  maternal serum 
screening for Down’s syndrome. Higher hCG 
levels after ART (fresh and frozen IVF or ICSI) 
than after spontaneous conception are usual 
(Perheentupa et al. 2002; Räty et al. 2002).
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Elective single embryo transfer
Multiple pregnancy occurs in 24.5–33.6% of  
gestations achieved via ART (The European 
IVF-monitoring programme (EIM) 2006; Wright 
et al. 2006). This means a more than twenty-fold 
increase in multiple pregnancies compared with 
spontaneous conception and is a consequence 
of  transferring more than one embryo at a time. 
The European Society for Human Reproduction 
and Endocrinology (EHSRE) has recommended 
halving the multiple pregnancy rate by increasing 
the number of  SETs (ESHRE Campus Course 
Report 2001). In clinics where SET represents 
50% or more of  all embryo transfers a twinning 
rate of  10% or less is achieved (Tiitinen and 
Gissler 2004). 
Great diversity in the number of  
transferred embryos exists among European 
countries and overall SET still represents a 
minority of  all embryo transfers (The European 
IVF-monitoring programme (EIM) 2006). The 
great variation in implementing active eSET 
policies depends on several factors (Gerris 2005). 
In some countries embryo selection has to be 
made at the oocyte stage, all cultured embryos 
may have to be transferred, or no embryo 
freezing is allowed. In other countries, eSET is 
encouraged by a reimbursement system (Belgium) 
or nationwide regulation (Sweden). In Finland 
the initiative to implement eSET was started 
in 1997 and driven by infertility professionals 
(Vilska et al. 1999). At fi rst the motive to 
perform eSET was to reduce the obstetric risks 
related to multiple pregnancies in women with a 
chronic illness, uterine malformation or previous 
preterm birth (Vilska et al. 1999). During the 
past decade the indications have broadened, 
but as yet no national recommendations exist. 
Currently, 46% of  Finnish embryo transfers are 
performed with a single embryo and 78% of  
these are performed as eSET (STAKES IVF-
statistics, unpublished data).
The fi rst convincing results after eSET 
were published by Vilska and colleagues in 1999 
(Vilska et al 1999). In their one-year cohort the 
clinical pregnancy rate per transfer was similar 
in the eSET and DET groups (29.7% vs. 29.4%) 
but the twin pregnancy rate was signifi cantly 
lower after eSET than after DET (0 vs. 23.9%) 
(Vilska et al. 1999). Thereafter, the results of  
both randomized studies and retrospective 
observational studies have confi rmed a total 
twinning rate after eSET comparable to that 
after spontaneous conception (Gerris et al. 1999; 
Martikainen et al. 2001; Tiitinen et al. 2001; 
Tiitinen et al. 2003; Thurin et al. 2004).  However, 
the rate of  monozygous twinning is higher (~1–
2%) after SET than after spontaneous conception 
(Alikani et al. 2003). 
The challenge of  active eSET policy, on 
the other hand, is to maintain acceptable overall 
pregnancy rates. According to the results of  
some randomized works and all retrospective 
observational studies with selected subjects, 
pregnancy and live birth rates comparable to those 
after DET can be achieved with elective transfer 
of  single embryos (Vilska et al. 1999; Martikainen 
et al. 2001; Tiitinen et al. 2001; Gerris et al. 2002; 
De Sutter et al. 2003; Tiitinen et al. 2003; Lukassen 
et al. 2005). In contrast to previous results 
signifi cantly lower pregnancy and live birth rates 
after one eSET than after one DET were found in 
the only existing prospective, randomized study 
(Thurin et al. 2004). However, if  supplementary 
transfer of  a frozen-thawed single embryo was 
combined with previous fresh eSET, pregnancy 
and live birth rates similar to those after one DET 
were achieved (Thurin et al. 2004). 
Pregnancy rates after eSET are largely 
infl uenced by the subjects’ characteristics. In the 
majority of  studies eSET is used among women 
with a high chance of  conceiving, i.e. younger 
women (age less than 35–37 years) having their 
fi rst or second fresh IVF or ICSI treatment. 
However, according to a recent review only 
~35% of  all infertile women belong to this 
highly selected subgroup, with good pregnancy 
and live birth rates (Gerris 2005). Indeed, when 
applying eSET to unselected women (i.e. no 
selection as regards woman’s age or embryo 
quality), pregnancy rates have been reported to 
be signifi cantly lower than after DET: 21.4% vs. 
40.3% (van Montfoort et al. 2006). Nevertheless, 
also similar pregnancy and live birth rates after 
eSET and DET in an observational study with 
women aged 36–39 years have also been found 
(Veleva et al. 2006).
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Obstetric and neonatal outcome after 
ART
The fi rst published studies on obstetric and 
neonatal outcome in pregnancies achieved by 
means of  ART in the 1980s suggested that an 
excess of  certain maternal complications, and 
preterm births, were characteristic of  these 
pregnancies (Australian in vitro fertilisation 
collaborative group 1985; Frydman et al. 1986; 
Steptoe et al. 1986). During the past twenty 
years many of  the initial discoveries have been 
verifi ed in numerous studies on obstetric and 
neonatal outcome of  ART singletons.
Course of  pregnancy
The frequencies of  specifi c maternal complica-
tions are presented in Table 2. According to age- 
and parity-matched studies, maternal vaginal 
bleeding in the fi rst trimester (OR 4.1; 95% CI 
3.6–4.8) and in the later trimesters (OR 2.7; 95% 
CI 1.4–5.5) is more typical of  singleton ART 
pregnancies than of  spontaneous singleton 
pregnancies (Koudstaal et al. 2000; Koivurova 
et al. 2002a; Källén et al. 2005a). First trimester 
vaginal bleeding may be related to the 10% 
vanishing twin survivor cohort in singleton ART 
pregnancies following DET (Pinborg et al. 2005; 
De Sutter et al. 2006a) but it is also frequent after 
single embryo transfer. First trimester bleeding 
increases the risk of  vaginal bleeding that occurs 
later in singleton ART pregnancies (De Sutter et 
al. 2006a). 
Vaginal bleeding in the second and third 
trimesters can be a sign of  abnormal placentation. 
According to the results of  two large cohort 
studies, placenta praevia was diagnosed in 
1.3%–1.6% of  singleton ART pregnancies, thus 
resulting in four- to fi vefold age- and parity-
adjusted risks of  placenta praevia (Källén et 
al. 2005a; Romundstad et al. 2006). Somewhat 
lower age- and parity-adjusted increased risks 
of  placenta praevia (OR 2.9; 95% CI 1.5–5.4) 
were noticed in a review of  fi fteen case-control 
studies concerning singleton ART pregnancies 
(Jackson et al. 2004). Along with more frequent 
vaginal bleeding and placenta praevia, increased 
risks of  placental abruption (OR 1.9; 95% CI 
1.4–2.5) and bleeding in association with vaginal 
delivery (OR 1.2; 95% CI 1.2–1.3) have been 
reported (Källén et al. 2005a).
In some studies pre-eclampsia (OR 1.2; 
95% CI 1.1–1.3) and gestational diabetes (OR 
2.0; 95% CI 1.4–3.0) have been reported to be 
more common in singleton ART pregnancies 
than in spontaneous singleton pregnancies 
(Jackson et al. 2004; Källén et al. 2005a). 
Premature rupture of  the membranes (adjusted 
OR 1.5; 95% CI 1.3–1.7) occurs more often in 
singleton ART pregnancies than in spontaneous 
singleton pregnancies (Källén et al. 2005a).
Mothers with singleton pregnancies after 
ART use outpatient care more frequently and are 
more often hospitalised during the pregnancy 
than mothers conceiving spontaneously 
(Koudstaal et al. 2000; Klemetti et al. 2002; 
Koivurova et al. 2002a; Källén et al. 2005a).
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Delivery 
Induction of  delivery is more typical of  singleton 
ART pregnancies than spontaneous singleton 
pregnancies (parity- and age- adjusted OR 1.4; 
95% CI 1.3–1.5) (Källén et al. 2005a). A similar 
rate of  vacuum extractions (Källén et al. 2005a) 
but a signifi cantly higher rate of  Caesarean 
sections (on average ~25%) than in spontaneous 
singleton pregnancies have consistently been 
observed (Klemetti et al. 2002; Helmerhorst 
et al. 2004; Jackson et al. 2004; Källén et al. 
2005a).
Postpartum complications 
Relatively few studies have been focused 
on the prevalence of  maternal postpartum 
complications. In a Finnish sample maternal 
hospitalisation seven days after delivery was 
more frequent in the ART cohort than in the 
spontaneously conceiving mothers (Klemetti 
et al. 2002). Longer hospitalisation after 
delivery is probably associated with more 
frequent Caesarean sections and prolonged 
healing. In addition, more frequent maternal 
complications may require time to settle and 
longer hospitalisation is needed. According to 
the results of  a Swedish Register-based study, re-
hospitalisation within two months after delivery, 
especially because of  bleeding, is more common 
in the ART cohort than in the spontaneous 
conception cohort (Källén et al. 2005a). 
Gestational age at birth, birth weight and 
neonatal complications
The frequency of  preterm births (< 37 weeks) 
in singleton pregnancies after ART has varied 
from 8.7% in a Finnish two-year cohort 
(Klemetti et al. 2002) to 14.1% in a one-year 
cohort in the United States (Schieve et al. 2004). 
The corresponding fi gure in singleton births 
following spontaneous conception was 4.8% 
in Finland in 1998–9. Thus in Finland the age-
, parity- and smoking-adjusted risk of  preterm 
birth was 1.8 (95% CI 1.5–2.1) (Klemetti et al. 
2002). In international studies an approximately 
twofold risk of  preterm birth in ART singletons 
has been indicated (Helmerhorst et al. 2004; 
Jackson et al. 2004). Very preterm birth (< 32 
weeks) also occurs more frequently in singleton 
ART gestations (~2%) than in singleton 
gestations following spontaneous conception 
(~1%) (Gissler et al. 1995a; Koivurova et al. 
2002b; Källén et al. 2005b). The age- and parity-
adjusted risk of  very preterm birth has been 
found to be signifi cantly increased (two- to 
threefold) (Helmerhorst et al. 2004).
Given that preterm birth contributes 
most to other neonatal outcomes it is not 
surprising that the rate of  infants with LBW 
(i.e. birth weight < 2500 g) is also relatively high 
(5.5% in Finland, 7.3% in Sweden, and 13.2% 
in the US) and the adjusted risk of  LBW lies 
between 1.5 to 2 (Klemetti et al. 2002; Schieve 
et al. 2002; Helmerhorst et al. 2004; Källén et al. 
2005b). Furthermore, the proportion of  infants 
with very low birth weight (VLBW: < 1500 g) 
after singleton ART pregnancy corresponds to 
the proportion of  infants born very preterm: i.e. 
1.7% to 2.6% (Koivurova et al. 2002b; Schieve 
et al. 2002; Schieve et al. 2004; Källén et al. 
2005b). Again in line with the age- and parity-
adjusted risk of  very preterm birth, the rate of  
VLBW is increased two- to threefold compared 
with that of  singleton infants from spontaneous 
conceptions (Koivurova et al. 2002b; Schieve et 
al. 2002; Helmerhorst et al. 2004; Schieve et al. 
2004). Gestational age-adjusted birth weight is 
reported only in some studies and the incidence 
of  small-for-gestational age (SGA) infants varies 
from 5% to 16% (Tan et al. 1992; Reubinoff  
et al. 1997; Koudstaal et al. 2000; Källén et al. 
2005b). Based on a meta-analysis, the adjusted 
risk of  SGA in singleton ART infants is 1.4 
(95% CI 1.2–1.7) (Helmerhorst et al. 2004). 
Due to increased rate of  preterm births 
low Apgar scores (< 7) at one minute of  age 
(5.7% vs. 4.3% [Klemetti et al. 2002]) and at fi ve 
minutes (2.6% vs. 1.3% [Källén et al. 2005b]) are 
signifi cantly more common in ART singletons 
than in spontaneously conceived singletons. 
Singletons from ART pregnancies are also 
admitted to a neonatal intensive care unit 
(NICU) more often than other singleton infants 
(adjusted OR 1.3; 95% CI 1.2–1.4) (Helmerhorst 
et al. 2004). Among neonatal complications the 
risk of  respiratory problems (OR 1.26; 95% CI 
1.15–1.43) is increased (Källén et al. 2005b).
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The perinatal mortality rate (PNMR) 
refers to stillbirths and deaths during the fi rst 
week of  life per 1000 births. Some discrepancy 
exists in the inclusion criteria as regards perinatal 
mortality fi gures in the medical literature, as 
some record stillbirths from the 20th gestational 
weeks onwards whereas others start at the 28th 
gestational week. In most of  the studies all 
stillbirths of  infants weighing at least 500 grams 
are recorded. Despite the differences, higher 
PNMRs (OR 1.7; 95% CI 1.1–2.6) in ART 
singleton births than in singleton births after 
spontaneous conception are reported in most 
studies (Helmerhorst et al. 2004). However, the 
signifi cantly increased risk of  perinatal mortality 
among singleton ART infants could not be 
confi rmed in a Finnish sample (Klemetti et al. 
2002).  
Congenital malformations
The frequency of  congenital malformations in 
singleton ART infants is estimated to be eight 
to nine per cent (Hansen et al. 2002; Källén 
et al. 2005c). Approximately half  of  these are 
classifi ed as major congenital malformations 
(a major structural anomaly, chromosomal 
defect, or congenital hypothyroidism) (Klemetti 
et al. 2005). Based on a meta-analysis, ART 
singleton infants are regarded to have a 30–
40% increased risk of  congenital anomalies 
when compared with singleton infants from 
spontaneous conceptions (Hansen et al. 2005). 
Additional risks of  neural tube defects, choanal 
atresia and alimentary tract atresia have been 
suggested, according to a Swedish register-
based study (Källén et al. 2005c). A higher 
rate of  cardiovascular anomalies has also been 
suggested in some studies (Hansen et al. 2002; 
Koivurova et al. 2002b), whereas no increase in 
the rate of  cardiovascular defects was found in 
larger samples (Klemetti et al. 2005; Källén et 
al. 2005c). 
Increased rates of  urogenital and 
musculoskeletal anomalies (Hansen et al. 2002; 
Klemetti et al. 2005), especially in singleton ART 
boys, has been noticed (Klemetti et al. 2005). 
Among urogenital anomalies, hypospadia is 
more frequent after ART than after spontaneous 
conception (Ericson and Källén 2001; Klemetti 
et al. 2005) and may be associated with male 
factor infertility (Ericson and Källén 2001). 
Recently a possible association between 
genetic imprinting (i.e. genetic silencing of  
either maternal or paternal alleles of  genes) 
and ART has been suggested. Both Angelman 
syndrome (Cox et al. 2002; Orstavik et al. 2003) 
and Beckwith-Wiedemann syndrome (DeBaun 
et al. 2003; Gicquel et al. 2003; Maher et al. 2003; 
Sutcliffe et al. 2006) have been linked to ART. In 
contrast, no excess of  imprinting disorders in a 
Danish National IVF cohort (1995–2001) was 
found (Lidegaard et al. 2005).
Infertility- and treatment-related factors 
and obstetric and neonatal risks 
The increased risks of  vaginal bleeding, placenta 
praevia, placental abruption, pregnancy induced 
hypertension, Caesarean section and preterm 
birth remain increased in singleton ART 
gestations even after controlling for known 
risk factors such as increased female age, parity 
and smoking (Cleary-Goldman et al. 2005; 
Duckitt and Harrington 2005). Obesity, (a well-
established risk-factor as regards gestational 
diabetes, gestational hypertension, pre-eclampsia 
and Caesarean delivery [Weiss et al. 2004a; 
Raatikainen et al. 2006; Villamor and Cnattingius 
2006]), on the other hand, is not frequently 
controlled for. However, obesity is not over-
presented among women conceiving with ART. 
Thus the observed increase in obstetric risks in 
ART singleton pregnancies imply that other and 
possibly infertility- or treatment-related factors 
may be involved in the development of  the 
above-mentioned obstetric complications.
In theory, one possible explanation 
for the increased obstetric risks in singleton 
ART gestations could be inadequate invasion 
of  cytotrophoblasts and associated abnormal 
placentation. Inadequate invasion of  
cytotrophoblasts to the spiral arteries has been 
implicated in the pathophysiology of  pre-
eclampsia (Kim et al. 2003; Redman and Sargent 
2005) and preterm labour (Kim et al. 2003). 
Further, the clinical manifestation of  inadequate 
cytotrophoblast invasion – fi rst trimester vaginal 
bleeding – is relatively common in singleton 
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ART gestation. First trimester bleeding, in 
turn, increases the risks of  pregnancy-induced 
hypertension, placental abruption (Nagy et al. 
2003; Weiss et al. 2004b) and preterm birth 
(Weiss et al. 2004b). In conclusion, many of  
the over-presented obstetric complications 
associated with ART may be mediated through 
inadequate placentation. In ART, altered 
hormonal, endometrial and embryological 
factors compared with spontaneous conception 
may contribute to the process of  implantation, 
but they are diffi cult if  not ethically impossible 
to study. 
In practice, infertility- and treatment-
related reasons for increased obstetric and 
neonatal risks have to be studied in terms 
of  clinically assessable measures. However, 
evaluation of  patient- and treatment-related 
factors as regards obstetric and neonatal 
outcomes after ART is diffi cult, as these factors 
coexist in women conceiving by means of  ART. 
In addition, very little prospectively collected 
data on the backgrounds of  infertile couples 
exists and registers usually lack information 
on the background of  infertility, or previous 
treatment attempts. 
Duration and aetiology of  infertility
One approach in the study of  reasons for the 
increased obstetric and neonatal risks is to 
compare the outcomes of  subfertile women 
who conceive spontaneously with those of  
women who conceive with the aid of  ART. 
The results of  population-based studies suggest 
that a prolonged time to pregnancy (> 12 
months) increases the risks of  preterm birth 
(Henriksen et al. 1997; Basso and Baird 2003) 
and perinatal (Draper et al. 1999) and neonatal 
mortality (Basso and Olsen 2005). In the above-
mentioned studies the increased risks were more 
pronounced in couples achieving pregnancy 
spontaneously than in couples conceiving by 
means of  infertility treatment. In contrast, in 
a recent Dutch population-based study it was 
claimed that the risks of  preterm birth and low 
birth weight are signifi cantly more increased 
in singletons following ART than in singletons 
born to subfertile but spontaneously conceiving 
women (Kapiteijn et al. 2006).
A prolonged time to pregnancy also 
increases the risk of  congenital malformations, 
irrespective of  ART (Zhu et al. 2006). However, 
an excess risk of  genital anomalies in singletons 
born to couples who received infertility treatment 
over those conceiving spontaneously has been 
observed (Zhu et al. 2006). The impact of  
duration of  infertility on obstetric and neonatal 
outcome in couples achieving pregnancy after 
ART has not been studied in detail.
Based on data from two nation-wide 
cohorts of  singleton ART pregnancies, couples 
with female factor infertility have increased 
risks of  preterm birth and having an infant 
with LBW compared with couples with male 
factor infertility (Schieve et al. 2004; Wang et al. 
2005). Among female factor-related infertility 
subgroups, women with tubal factor infertility 
may be at an increased risk of  preterm birth 
versus women with unexplained infertility 
(Omland et al. 2005).
Hormonal stimulation
The adverse obstetric and neonatal outcomes in 
singleton pregnancies after ART might also be 
related to hormonal stimulation, or IVF and ICSI 
methods rather than to underlying infertility. 
This has been studied by comparing obstetric 
and neonatal outcomes in pregnancies achieved 
by means of  ovarian stimulation without 
gonadotrophin agonist down-regulation (OS), 
and intrauterine insemination (IUI), pregnancies 
achieved by means of  IVF or ICSI and 
pregnancies after spontaneous conception. Data 
on the prevalence of  obstetric complications 
in such groups is scarce. An increased risk of  
placental abruption and foetal loss after the 24th 
gestational week in the OS/IUI group compared 
with the spontaneously conceiving controls has 
been noticed but no comparison between the 
OS/IUI and the IVF/ICSI groups has been 
carried out (Shevell et al. 2005). Preterm and very 
preterm birth (Ombelet et al. 2006), and LBW 
infants (Nuojua-Huttunen et al. 1999; Gaudoin 
et al. 2003; Ombelet et al. 2006) occur more 
frequently in the OS/IUI subgroup than in the 
spontaneous conception group. However, in the 
OS/IUI subgroup, neonatal outcome similar to 
that in the IVF/ICSI group has been confi rmed 
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in two studies (Nuojua-Huttunen et al. 1999; 
De Sutter et al. 2005), whereas more preterm 
births after IVF/ICSI than after OS/IUI were 
found in another study (Wang et al. 2002b). To 
conclude, the comparable neonatal outcomes in 
the OS/IUI and IVF/ICSI groups indicate that 
either the patients’ background or the hormonal 
stimulation but not the IVF or ICSI methods 
themselves seem to be responsible for the higher 
risks compared with controls.
Type of  treatment of  infertility
Only limited information exists in respect to 
different ART modalities (IVF vs. ICSI, fresh vs. 
frozen embryo transfer). The risks of  preterm 
birth and LBW are similar in ICSI and IVF 
subgroups (Bonduelle et al. 2002; Schieve et al. 
2004). However, singleton gestations achieved 
by means of  FET are linked to decreased risks 
of  preterm birth (Källén et al. 2005b; Wang et 
al. 2005) and LBW (Aytoz et al. 1999; Källén et 
al. 2005b; Wang et al. 2005; Wright et al. 2006) 
compared with singletons achieved by means of  
fresh embryo transfer. 
Number of  transferred embryos
Keeping in mind the fact that an active eSET 
policy began a little less than a decade ago, it 
is not surprising that only a few studies on its 
infl uence on obstetric and neonatal outcome are 
published. 
To date, three studies, involving a total 
of  782 singleton pregnancies after SET and 
resulting in a live birth have been presented (De 
Neubourg et al. 2006; De Sutter et al. 2006b; 
Kjellberg et al. 2006). In all these studies good-
prognosis patients receiving a good quality 
embryo were included and data were received 
from the clinics’ own databases or from self-
submitted questionnaires. 
Pregnancy induced hypertension is more 
frequent after SET than after spontaneous 
singleton conception (7.6% vs. 4.6%, p = 
0.02) (De Neubourg et al. 2006). Vaginal 
bleeding thoughout the pregnancy and preterm 
contractions were reported in 14.3% (both) of  
SET pregnancies (De Neubourg et al. 2006), 
but no comparison with the controls could 
be carried out. The Caesarean section rate in 
the SET groups ranged from 20 to 23% (De 
Neubourg et al. 2006; Kjellberg et al. 2006).
According to the study by De Sutter 
and colleagues the mean gestational duration 
at birth was longer (39.4 vs. 39.1 weeks, p < 
0.001) and the mean birth weight was greater 
(3324 g vs. 3204 g, p < 0.01) than in singleton 
pregnancies following DET (De Sutter et al. 
2006b). In contrast, no difference in median 
gestational duration (40 vs. 40.3 weeks, p = 
0.26) or in mean birth weight (3550 g vs. 3405 
g, p = 0.20) between SET and DET singleton 
groups in a randomised controlled study was 
noticed (Kjellberg et al. 2006). Further, similar 
gestational durations (38.7 vs. 38.9 weeks, p = 
0.06) and mean birth weights (3322 g vs. 3330 
g, p = 0.82) in comparison with spontaneous 
singleton pregnancies have also been suggested 
(De Neubourg et al. 2006).
The incidence of  preterm births in the 
SET groups was 6.2% according to De Sutter 
and colleagues (De Sutter et al. 2006b) but close 
to 10% in the other two studies (De Neubourg 
et al. 2006; Kjellberg et al. 2006). The incidence 
of  LBW after SET was 4.2% to 7.0% in these 
studies. Because neonatal complications were 
reported differently and the number of  neonatal 
complications was relatively low in the above-
mentioned studies, no conclusion regarding 
the impact of  SET on neonatal health can be 
drawn.
Ten to eighteen percent of  singletons 
born after DET are survivors of  an original 
twin gestation – i.e. vanishing twin survivors 
(Pinborg et al. 2005; Lambers et al. 2006; La Sala 
et al. 2006). Cessation of  development of  the co-
twin can have an adverse impact on pregnancy 
outcome, especially if  it occurs after eight weeks 
of  gestation (Pinborg et al. 2005).
A vanishing twin pregnancy may become 
manifest with fi rst trimester bleeding (De Sutter 
et al. 2006a). Pre-eclampsia is suggested to be 
more common in vanishing twin pregnancies 
than in singleton pregnancies (Chasen et al. 
2006a). The mean length of  pregnancy is shorter 
(Dickey et al. 2002; Schieve et al. 2004; Pinborg 
et al. 2005), and the frequency of  preterm and 
very preterm births is higher (Pinborg et al. 2005) 
in the vanishing twin survivor cohort than in 
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the singleton cohort following implantation of  
a single embryo. Consequently, the mean birth 
weight is lower (Dickey et al. 2002; Schieve et al. 
2004; Pinborg et al. 2005) and the proportions 
of  infants with LBW and VLBW are elevated 
in vanishing twin pregnancies versus singletons 
originating from a single gestational sac. The 
cessation of  embryonal/foetal development of  
a co-twin can also have life-long consequences 
on the survivor’s health: according to two 
population-based cohort studies the prevalence 
of  cerebral palsy (Pharoah and Adi 2000; 
Hvidtjorn et al. 2005) and other forms of  
cerebral impairment (Pharoah and Adi 2000) 
are increased.
The poorer neonatal outcome of  the 
vanishing twin cohort following DET may 
confound the overall neonatal results of  ART 
singletons, because the majority of  the published 
studies on the outcome of  singleton pregnancies 
after ART concern singleton pregnancies 
following DET. 
Psychological features of  pregnancy
Pregnancy is a period of  intense emotional 
processing and preparation for a permanent 
life change, particularly for fi rst-time parents. 
During pregnancy both parents-to-be work 
through their experiences and expectations of  
parenthood and create an emotional bond with 
the infant (Broden 2006). Ambivalent feelings 
towards the pregnancy and the infant are part of  
this process and optimally these feelings diminish 
as the pregnancy proceeds. For a father-to-be the 
physiological process that occurs in a pregnant 
woman may raise feelings of  being outside. 
Integrating the concepts of  a mother and a 
spouse into one person may also be demanding 
for an expectant father (Haukkamaa 2000). 
Optimally, the expectant couple can establish an 
attachment to the foetus together and support 
one another with the physical and psychological 
demands of  pregnancy.
Pregnancy after ART
Achieving an ongoing pregnancy after ART 
usually follows years of  uncertainty regarding 
a couple’s possibility to ever become parents. 
For many couples infertility, the associated 
investigations and ART raise feelings of  stress, 
anxiety and depression (Beaurepaire et al. 1994; 
Visser et al. 1994; Bringhenti et al. 1997; Lukse 
and Vacc 1999; Souter et al. 2002; Verhaak et al. 
2005; Verhaak et al. 2006). Anxiety and stress 
associated with ART are also among the most 
important reasons for discontinuing further 
treatments (Olivius et al. 2004; Rajkhowa et 
al. 2006). In general, women experience more 
ART-related distress than their spouses (Wright 
et al. 1991; Slade et al. 1997; Hjelmstedt et 
al. 1999; Holter et al. 2006). The impact of  
the number of  previous unsuccessful ART 
cycles and the duration of  infertility on ART-
related anxiety is controversial: some state that 
stress, depressiveness and somatic symptoms 
increase after cumulative ART attempts or a 
long duration of  infertility (Abbey et al. 1992; 
Domar et al. 1992; Boivin et al. 1995; Kee et 
al. 2000), whereas others have not found an 
association (Lukse and Vacc 1999; Verhaak et al. 
2005). The impact of  the aetiology of  infertility 
on psychological distress has scarcely been 
studied. Before the time of  ICSI, couples with 
male factor infertility regarded their distress as 
being more severe than that among couples with 
other aetiological backgrounds (Connolly et al.. 
1992). Thereafter, no difference in psychological 
variables in infertile couples has been confi rmed 
(Wischmann et al. 2001).
Although anxiety and depressive 
symptoms affect 20–30% of  infertile women 
during ART (Souter et al. 2002; Verhaak et 
al. 2005), these symptoms usually diminish 
or become resolved when the long-awaited 
pregnancy starts (Wright et al. 1991; Verhaak et 
al. 2005). With the exception of  one study (van 
Balen et al. 1996), the majority of  investigators 
have confi rmed similar levels of  general anxiety, 
depressiveness and low self-esteem during 
pregnancy among women conceiving by means 
of  ART and those conceiving spontaneously 
(McMahon et al. 1997; Klock and Greenfeld 2000; 
Hjelmstedt et al. 2003). However, assessment 
of  general anxiety may not be sensitive enough 
when considering pregnancy-specifi c anxiety 
(Huizink et al. 2004). Indeed, higher levels of  
pregnancy-specifi c anxiety in pregnant ART 
women than in control pregnant women 
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have been found in some studies (McMahon 
et al. 1997; Hjelmstedt et al. 2003). Women 
conceiving by means of  ART tend to be more 
anxious over loss of  pregnancy and are more 
concerned about the infant’s health and possible 
injury during delivery than control women 
(McMahon et al. 1997; Hjelmstedt et al. 2003). 
Worry about the threat of  losing the pregnancy 
and not having a healthy child is suggested to be 
related to the number of  treatment cycles and 
infertility-related distress (McMahon et al. 1997; 
Hjelmstedt et al. 2003).
Fear-of-childbirth and pregnancy-related 
anxiety
Mild to moderate fear-of-childbirth and 
pregnancy-related anxiety are common (Areskog 
et al. 1981; Melender 2002) and can be considered 
as normal dimensions of  a woman’s emotional 
maturation regarding her new role as a mother. 
Nevertheless, for 6–13% of  pregnant women 
fear-of-childbirth becomes a serious problem 
negatively affecting their psychosocial well-being 
and social relationships (Areskog et al. 1981; 
Söderquist et al. 2004). Fear-of-childbirth can 
be considered a multifactorial anxiety disorder 
which correlates with pregnancy-related anxiety 
(Saisto et al. 2001a). Previous studies have 
shown that women with fear-of-childbirth more 
frequently suffer from nausea and vomiting 
(Swallow et al. 2004), are on sick-leave, visit their 
obstetricians (Andersson et al. 2004) and request 
Caesarean section in comparison with women 
without such fear. According to Areskog and 
colleagues, women who complain of  fear-of-
childbirth are more likely to experience delivery 
less favourably than other parturients (Areskog 
et al. 1983). More recently, labour pain and 
operative delivery rather than preceding fear-
of-childbirth have most accurately been proven 
to predict disappointment with delivery (Saisto 
et al. 2001b). Fear-of-childbirth may occupy a 
woman’s mind and building an attachment to the 
child may become diffi cult (Areskog et al. 1984). 
Further, fear-of-childbirth may be a reason for 
not becoming pregnant again (Bahl et al. 2004).
Several psychosocial and obstetric 
factors contribute to the probability of  being 
afraid of  delivery or experiencing pregnancy-
related anxiety (Table 3). In general, nulliparous 
women experience moderate fear-of-childbirth 
and pregnancy-related anxiety more often than 
parous women (Areskog et al. 1983; Wijma et al. 
1997; Alehagen et al. 2001; Saisto et al. 2001a; 
Johnson and Slade 2002; Söderquist et al. 2004). 
Severe fear-of-childbirth and post-traumatic 
stress disorder, on the other hand, are more 
typical of  parous parturients than of  nulliparous 
parturients (Söderquist et al. 2004). In parous 
parturients previous complicated or operative 
delivery is the most important underlying reason 
for fear-of  childbirth (Ryding et al. 1997; Sjögren 
1997; Saisto et al. 1999). In addition, negative 
life experiences (Areskog et al. 1983), psychiatric 
disorders (Andersson et al. 2003; Söderquist et 
al. 2004), general anxiety (Saisto et al. 2001a; 
Söderquist et al. 2004), lack of  social support 
(Saisto et al. 2001a; Söderquist et al. 2004) and 
unemployment (Saisto et al. 2001a) are common 
risk factors for fear-of-childbirth and pregnancy-
related anxiety. 
Fear-of-childbirth and pregnancy-related 
anxiety in women undergoing ART have been 
assessed only in four studies. Previous infertility 
has not been found to be an independent 
predictor of  fear-of-childbirth in subsequent 
pregnancy (Saisto et al. 1999). Because 70–80% 
of  women conceiving via ART are expecting 
their fi rst child, more frequent moderate fear-
of-childbirth than in the general pregnant 
population would be expected. In addition, 
more pronounced anxiety over possible loss 
of  pregnancy and over the infant’s health in 
women conceiving by means of  ART than in 
spontaneously conceiving women (McMahon et 
al. 1997; Hjelmstedt et al. 2003) might be a sign 
of  underlying fear-of-childbirth. 
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Assessing fear-of-childbirth and
 pregnancy-related anxiety
Defi ning fear-of-childbirth and pregnancy-
related anxiety is diffi cult because they both 
entail many different features associated with 
pregnancy and giving birth. They both share 
aspects of  being afraid or anxious about pain, 
tearing and maternal death during delivery, 
losing self-control and having an injured or 
malformed infant. To date, no internationally 
accepted defi nitions of  fear-of-childbirth or 
pregnancy-related anxiety exist.
Measuring fear-of-childbirth and 
pregnancy-related anxiety has not been settled 
either. The fi rst questionnaire used to assess 
fear-of-childbirth was generated by Areskog 
and colleagues in the late seventies (Areskog 
et al. 1982). They interviewed a sample of  139 
pregnant women and analysed how well their 
self-expressed fear-of-childbirth and the scores 
of  their 19-item fear-of-childbirth questionnaire 
(FDQ) correlated at the 31st to 33rd gestational 
week (Areskog et al. 1982). The original fear-
of-childbirth questionnaire was revised in 
subsequent studies in order to suit the studied 
population (Di Renzo et al. 1984; Wijma et al. 
1998). In the late nineties Saisto et al. applied a 
revised ten-item version of  the fear-of-childbirth 
questionnaire in an unselected Finnish pregnant 
population and it proved to be a reliable and 
valid tool for measuring fear-of-childbirth in 
Finnish samples (Saisto et al. 2001a). 
Similarly, inconsistency in measuring 
pregnancy-related anxiety characterises the 
studies in this area. In 1991, Levin revised the 
pregnancy anxiety scale (PAS) originally created 
in 1974 (Burstein et al. 1974; Levin 1991). 
The PAS has ten questions that cover three 
dimensions of  anxiety: anxiety about being 
pregnant, anxiety about childbirth and anxiety 
about hospitalisation. Saisto et al. have also 
validated the PAS to suit unselected pregnant 
Finnish women (Saisto et al. 2001a).
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Table 3. Predisposing factors regarding fear-of-childbirth.
Predisposing 
factor
Reference n Study setting Assessment 
time
Criteria for
fear-of-childbirth
Obstetric
Nulliparity Areskog, 1983 176 cross-sectional h31-33 FDQ ≥ 6
Di Renzo, 1984 810 cross-sectional h38-41 rFDQ (20)
Wijma, 1997 1640 cross-sectional, 
retrospective
1-13 months
postpartum
W-DEQ ≥ 85
Alehagen, 2001 74 cross-sectional at delivery DFS
Johnson, 2002 443 cross-sectional h32 W-DEQ ≥ 85
Söderquist, 2004 995 prospective h32 W-DEQ ≥ 85
Previous 
Miscarriage
Saisto, 1999 300 cross-sectional, 
retrospective
subsequent 
pregnancy
a request for CS
Previous 
operative delivery
Ryding, 1997 25 retrospective 1 week and 
1-2 months 
postpartum
DSM-IIIR
Sjögren, 1997 100 retrospective h20-35 self-expressed 
extreme fear of  
childbirth
Jolly, 1999 480 retrospective 5 years after 
delivery
postal questionnaire
Saisto, 1999 300 cross-sectional, 
retrospective
subsequent 
pregnancy
a request for CS
Psychosocial
Psychiatric 
disorders
Anderson, 2003 1556 cross-sectional h16-17 PRIME-MD
Söderquist, 2004 995 prospective h32 W-DEQ ≥ 85
General anxiety Saisto, 2001a 278 cross-sectional h30 rFDQ (10) ≥ 6
Söderquist, 2004 995 prospective h32 W-DEQ ≥ 85
Negative life 
experiences
Areskog, 1983 176 cross-sectional h31-33 FDQ  ≥ 6
Lack of  social 
support
Saisto, 2001a 278 cross-sectional h30 rFDQ (10)  ≥ 6
Söderquist, 2004 995 prospective h32 W-DEQ ≥ 85
Unemployment Saisto, 2001a 278 cross-sectional h30 rFDQ (10)  ≥ 6
Dissatisfaction 
with partnership
Saisto, 2001a 278 cross-sectional h30 rFDQ (10) ≥ 6
CS = Caesarean section
DFS = Delivery Fear Scale, range 1–10
DSM-IIIR = Diagnostic and statistical manual of  mental disorders, third revised version
FDQ = fear-of-childbirth questionnaire, original 19-item version
h = gestational weeks
rFDQ() = revised version of  FDQ, number in parenthesis indicates the number of  included items
PRIME-MD = Primary Care Evaluation of  Mental Disorders
W-DEQ = Wijma Delivery Expectancy/Experience Questionnaire, range 0–165
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AIMS OF THE STUDY
The present study was undertaken to investigate the outcome of  singleton ART pregnancy.
The specifi c aims were:
1. to evaluate the predictive value of  a single hCG measurement in determining the outcome 
of  ART 
2. to analyse the impact of  infertility- and treatment-related characteristics on obstetric and 
neonatal outcome 
3. to compare the obstetric and neonatal outcome of  singleton pregnancies following SET, 
DET and spontaneous conception   
4. to study the prevalence and contributing factors of  fear-of-childbirth and pregnancy-
related anxiety in women conceiving by means of  ART
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SUBJECTS AND METHODS
These studies involved infertile patients from 
the Infertility Clinics of  Helsinki University 
Central Hospital, the Family Federation of  
Finland (Helsinki, Oulu and Turku) and the 
Deaconess Institute (Helsinki). Studies I and III 
were approved by the Administrative Head of  
the Department of  Obstetrics and Gynaecology, 
Helsinki University Central Hospital. In Study 
III the National Research and Development 
Centre for Welfare and Health (STAKES) gave 
permission to use register data and to perform 
data linkages between different health registers. 
Studies II and IV were approved by the Ethics 
Committee of  the Department of  Obstetrics 
and Gynaecology, Helsinki University Central 
Hospital, the Family Federation of  Finland and 
the Deaconess Institute and the subjects gave 
their informed consent before participation.
Subjects
Detailed characteristics of  the subjects according 
to each study are given in Table 4.
Study I
The study subjects consisted of  a retrospective 
cohort of  650 women with 774 ART cycles. They 
received fresh or frozen IVF or ICSI treatment 
at the infertility clinic of  Helsinki University 
Central Hospital in 1994–1999.
Studies II & IV
The subjects comprised female participants 
with singleton pregnancies from a prospective 
controlled follow-up study on somatic and 
mental health after ART. The women in the ART 
group were recruited after a viable pregnancy 
was confi rmed at the infertility clinics of  
Helsinki University Central Hospital, the Family 
Federation of  Finland (Helsinki, Oulu and 
Turku) and the Deaconess Institute (Helsinki) 
in 1999. Pregnancies achieved with the couples’ 
own gametes and with fresh or frozen IVF or 
ICSI treatment were included. 
Consecutive, spontaneously conceiving 
control women were recruited from screening 
ultrasonographic scan appointments at 
gestational weeks 16–18 at the Maternity Clinic 
of  Helsinki University Central Hospital in 1999. 
The exclusion criteria for the control women 
were previous infertility or infertility treatment, 
age less than 25 years and diffi culties in Finnish 
comprehension. A total of  367 (92.4%) out of  
397 initially recruited women in the ART group 
and 379 (81.7%) out of  464 control women 
participated in the fi rst questionnaire assessment 
at the 20th gestational week (p < 0.001). At the 
second questionnaire assessment eight weeks 
postpartum 324 (88.3%) women in the ART 
group and 304 (80.2%) women in the control 
group took part (p = 0.03).
Study III
Women having a viable singleton pregnancy 
after fresh SET (n = 270) or DET (n = 231) 
at the infertility clinic of  Helsinki University 
Central Hospital in 1997–2003 were identifi ed 
retrospectively from the patient records. The 
identifi ed pregnancies and the infants born were 
linked to the Finnish Medical Birth Register 
(MBR), the Hospital Discharge Register (HDR) 
and the Register of  Congenital Malformations 
(RCM) according to the maternal and infant 
identifi cation numbers. Two of  these 501 
pregnancies ended in selective termination in 
the second trimester and the remaining 499 
pregnancies, 269 after SET and 230 after DET, 
formed the fi nal ART group.   The control 
group (n = 15 037) was randomly taken from 
the MBR. The controls represent a ten per 
cent population-based sample of  women with 
spontaneous singleton pregnancies and infants 
born matched for the year of  delivery and 
mother’s place of  residence. 
ART treatment protocols
Ninety-eight per cent of  fresh IVF and ICSI 
cycles were started with long luteal phase 
pituitary down-regulation with nafarelin or 
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buserelin. After two weeks of  down-regulation 
rFSH was added for ovarian stimulation. When 
two or more follicles reached a diameter of  > 17 
mm in TVS, exogenous hCG was administered. 
Oocyte retrieval took place 34–36 h after 
hCG administration. Embryo transfers were 
performed two to three days after insemination. 
Micronized vaginal progesterone (600 mg) was 
used for luteal support for two weeks. 
In FET cycles, embryo transfers were 
completed both in natural and substituted cycles. 
In natural FET cycles embryo transfer took place 
three days after the LH surge was measured with 
a home test kit. Luteal support was provided 
with micronized vaginal progesterone (200 
mg) for two weeks. In substituted FET cycles 
oral oestrogen (4–6 mg daily) was started in 
the fi rst days of  the menstrual cycle. When 
the endometrium had reached a minimum 
thickness of  7 mm in TVS, micronized vaginal 
progesterone at a daily dose of  600 mg was 
added to the hormonal substitution. Embryo 
transfer was carried out usually three to four 
days after initiation of  progesterone treatment. 
Both types of  medication were continued until 
the 10th gestational week in viable pregnancies.
Treatment outcome was monitored with 
serum hCG sampling and TVS.
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Table 4. Subject characteristics in Studies I–IV.
Aetiology of  infertility Treatment type
n Age
(y)
Nulli-
parous
Female Male Combined Un-
explained
IVF ICSI FET
mean 
(SD)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
I
ART 774* 32
(4)
- 387 
(50)
128 
(17)
56 
(7)
203 
(26)
518 
(67)
119 
(15)
137 
(18)
II
ART 324 33
(4)
227 
(70)
107 
(33)
88 
(27)
61 
(19)
68 
(21)
128 
(40)
59 
(18)
137 
(42)
Controls 304 33
(3)
104 
(34)
III
SET 269 33
(4)
215 
(80)
142 
(53)
51 
(19)
19 
(7)
57
 (21)
201 
(75)
68 
(25)
-
DET 230 34
(4)
187 
(81)
98
(43)
53 
(23)
13 
(6)
66 
(29)
167 
(73)
63 
(27)
-
Controls 15037 30
(5)
6588 
(44)
IV
ART 367 33
(4)
260 
(71)
122 
(33)
95 
(26)
71 
(19)
79 
(22)
146 
(40)
70 
(19)
151 
(41)
Controls 379 33
(3)
135 
(36)
* number of  studied treatment cycles 
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Table 5. Study design according to the original publications. 
Study I II III IV
Setting retrospective prospective, 
controlled
retrospective prospective, 
controlled
Data source patient records questionnaire 
survey,
patient records
MBR, HDR, RCM questionnaire 
survey,
patient records
End-point of  
data collection
sixth week 
postpartum or 
after cessation of  
pregnancy
eighth week 
postpartum
sixth week 
postpartum
20th gestational 
week
Main 
assessment 
variable(s)
serum hCG 12 
days after ET
aetiology and 
duration of  
infertility, 
treatment type
number of  
transferred 
embryos 
(i.e. SET vs. DET)
rFDQ, PAS
Main study 
question
prediction of  ART 
outcome
evaluation of  
risk of  adverse 
pregnancy 
outcomes 
with patient 
characteristics
impact of  the 
number of  
transferred 
embryos on 
obstetric and 
neonatal outcome
prevalence of  fear-
of-childbirth and 
pregnancy-related 
anxiety
Hypothesis patient-related 
factors alter the 
predictive value of  
hCG
patient 
characteristics 
relate with 
adverse pregnancy 
outcomes
SET associates with 
improved obstetric 
and neonatal 
outcome
fear-of-childbirth 
and pregnancy-
related anxiety are 
more frequent after 
ART
ART = assisted reproductive treatment
DET = double embryo transfer
ET = embryo transfer
hCG = human chorionic gonadotrophin
HDR = Hospital Discharge Register
MBR = Medical Birth Register
PAS = pregnancy anxiety scale
rFDQ = revised version of  the fear-of-childbirth questionnaire
SET = single embryo transfer
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Methods
The data was collected from patient records (I–
IV), structured questionnaires (II and IV) and 
from national Health Registers (III). Detailed 
description of  the data sources and assessed 
variables is given below. The study designs are 
summarised in Table 5.
Assay of  hCG (I)
Serum intact hCG was measured twelve days 
after embryo transfer by solid phase, two-site 
fl uoroimmunometric assay (AutoDELFIA®; 
Wallac, Turku, Finland). The intra-assay variation 
was 2.7–5.1% and inter-assay variation 1.6–3.9% 
at the studied hCG levels. The standard had been 
calibrated against the WHO Third International 
standard of  hCG for immunoassay (code 
75/537).
Questionnaire survey (II and IV)
The fi rst questionnaire was given to the 
participants at recruitment and it was returned 
at a mean (± SD) of  20 (± 3.2) gestational 
weeks. The fi rst questionnaire included multiple 
choice questions concerning social background 
(education, employment and partnership), 
general health (presence of  a chronic illness 
and need of  continuous medication), tobacco 
smoking (0, <5, 5–10, >10 cigarettes per day), 
alcohol consumption (0, <5, ≥5 units per week) 
and somatic problems (hyperemesis, vaginal 
bleeding and other not specifi ed) in the studied 
pregnancy.
The second questionnaire was mailed 
to the participants after the research nurse had 
contacted them after delivery. This questionnaire 
was returned at a mean (± SD) of  eight (± 3.4) 
weeks postpartum. In the second questionnaire 
the participants were asked to report whether they 
had had any pregnancy complications (preterm 
contractions, vaginal bleeding, gestational hyper-
tension, pre-eclampsia, gestational diabetes 
or cholestasis in pregnancy) and related 
hospitalisation after the 20th gestational week. 
The onset (spontaneous or induced) and the type 
(vaginal, vacuum extraction, Caesarean section) 
of  delivery were addressed in multiple choice 
questions. The health of  the newborns was 
assessed via questions concerning gestational 
age at birth, birth weight and height, Apgar 
scores, general health, and need of  admittance 
to a NICU and length of  stay there. Perinatal 
mortality rate referred to all stillbirths and deaths 
of  newborns (weighing ≥ 500 g) occurring from 
the 22nd completed gestational week to the age 
of  six days.
In addition to the two  above-mentioned 
questionnaires, data on age, BMI, obstetric 
history and detailed information concerning 
previous and current ART were collected at 
recruitment. Mean gestational age, mean birth 
weight and Apgar scores of  infants were checked 
from the clinics’ patient records.    
Register data (III)
The Finnish Medical Birth Register (MBR)
The MBR includes data on maternal 
characteristics, and obstetric and neonatal 
outcomes of  all live births and stillbirths of  
infants/foetuses born after the 22nd gestational 
week or weighing at least 500 g. The data 
is submitted by the delivery hospitals and 
completed by data from the Population Register 
Centre and Cause-of-Death Register at Statistics 
Finland. The Coverage of  the MBR is practically 
100% (Gissler et al. 1995b).
The Hospital Discharge Register (HDR)
The HDR receives yearly data on outpatient 
and inpatient care from hospitals. The data 
is collected according to the instructions of  
The National Research and Development 
Centre of  Welfare and Health and categorised 
according to the 10th version of  the international 
Classifi cation of  Diseases (ICD 10) and to the 
national version of  the Nordic Classifi cation of  
Surgical Procedures. 
The Register of  Congenital Malformations (RCM)
The RCM contains data on congenital anomalies 
diagnosed during the child’s fi rst year of  life 
from hospitals, health-care professionals, 
cytogenetic laboratories and health registers of  
STAKES (National Research and Development 
Centre for Health and Welfare) and Statistics 
Finland. The coverage and validity of  RCM 
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data is good after multi-source data collection. 
A congenital anomaly is defi ned as a structural 
anomaly, a chromosomal defect or congenital 
hypothyroidism in live births, stillbirths and in 
selective terminations of  pregnancy. Congenital 
anomalies are registered and included in the 
RCM according to instructions from European 
Surveillance of  Congenital Anomalies. 
The included maternal variables from the 
MBR, HDR and RCM were age, socio-economic 
status (SES), number and type of  previous 
pregnancies and deliveries, smoking, number of  
outpatient visits, obstetric complications (ICD 
10 codes O10–O99), prevalence of  maternal 
hospitalisation during the pregnancy, onset and 
type of  delivery, and surgical procedures. The 
neonatal variables included were gestational age 
at birth (defi ned according to the best clinical 
estimation), birth weight, SGA (according to 
national sex-specifi c standards [Pihkala et al. 
1989]), low one-minute Apgar scores (0–6), 
admission to a NICU, perinatal deaths (stillbirths 
and neonatal deaths during the fi rst week of  life) 
and presence of  congenital malformations. 
Revised version of  the Fear-of-Childbirth 
Questionnaire and the Pregnancy Anxiety Scale 
(IV)
Fear-of-childbirth was assessed with the revised 
version of  the fear-of-childbirth questionnaire 
(rFDQ). The rFDQ consisted of  11 dichotomous 
questions giving a possible range of  sum scores 
from 0 to 11. Affi rmative answers indicated fear-
of-childbirth. The sum score of  the rFDQ was 
non-normally distributed and therefore medians 
were used. The reliability of  the rFDQ was 0.72 
(Cronbach’s alpha). 
Pregnancy-related anxiety was assessed 
by means of  the Pregnancy Anxiety Scale (PAS). 
This consisted of  ten fi ve-scale questions giving 
a possible “range” of  sum scores from ten to 
fi fty. High scores in the individual questions and 
in the sum score indicated pregnancy-related 
anxiety. The PAS sum scores and scores in three 
sub-dimensions were non-normally distributed 
and medians are given. The reliability of  the 
PAS in our sample was 0.80 (Cronbach’s alpha). 
The contents of  rFDQ and PAS are given in 
Appendix.
Severe fear-of-childbirth and severe 
pregnancy-related anxiety were regarded as sum 
scores equal to or greater than the 90th percentile 
of  sum scores (i.e. rFDQ scores ≥ 6 and PAS 
scores ≥ 30, respectively). The prevalence of  
severe fear-of-childbirth and severe pregnancy-
related anxiety was studied fi rst between the 
ART and the control groups and then separately 
among nulliparous and parous participants. 
Statistical analyses
In cases of  normally distributed continuous 
variables Student’s t-test (I–IV) and one-way 
analysis of  variance (ANOVA) were used (I–
III). In study I an exponential transformation of  
hCG values in viable pregnancies gave a good 
fi t. With non-normally distributed continuous 
variables the Mann–Whitney U-test (I, II) and 
Kruskal–Wallis analysis of  variance (I) were 
run. For comparison of  proportions the χ2-
test or Fisher’s exact test were performed when 
applicable (I–IV). In study I a receiver operating 
characteristic curve (ROC) was utilised to 
defi ne the most suitable hCG cut-off  level 
to distinguish between viable and non-viable 
pregnancies. In studies II–IV adjusted multiple 
logistic regression analyses were carried out.
A probability level of  < 0.05 was regarded 
as statistically signifi cant. Statistical analyses 
were performed by using NCSS 2000 (NCSS 
Inc., Kaysville, Utah), SPSS version 12.0.1 (SPSS 
Inc., Chicago, IL) and the eighth version of  SAS 
(SAS Institute, Cary, NC) software.
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RESULTS
Serum hCG in predicting the outcome 
of  ART (I)
The median hCG concentration was higher in 
viable than in non-viable pregnancies (126 IU/
L vs. 31 IU/L, p < 0.0001). A cut-off  value of  
76 IU/L predicted viable pregnancies with 80% 
sensitivity, 82% specifi city, and had 87% PPV 
and 74% NPV. 
Probability of  various pregnancy out-
comes according to deciles of  serum hCG 
concentrations are given in Figure 3.
Among viable singleton pregnancies, 
male factor infertility and ICSI treatment were 
associated with the lowest median hCG values 
(83 IU/L vs. 120 IU/L, p = 0.001). Median hCG 
concentrations were similar in fresh and frozen 
embryo transfer groups (114 IU/L vs. 115 IU/
L, NS). Further, the median hCG level did not 
differ in singleton pregnancies following transfer 
of  either one or two embryos (104 IU/L vs. 119 
IU/L, NS). 
We also studied whether hCG con-
centrations and the gestational age- and sex-
adjusted weights of  singleton infants were 
correlated, but no signifi cant correlation was 
found.
Figure 3. Probability of  various pregnancy outcomes according to deciles of  serum hCG 
concentration 12 days after embryo transfer.
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Infertility- and treatment-related 
factors and obstetric and neonatal 
outcome (II)
In general, the prevalence of  maternal pregnancy 
complications was similar in the ART and the 
control group, but hospitalisation before delivery 
was more typical of  the mothers in the ART 
group than those in the control group (18.8% 
vs. 11.2% respectively, p = 0.006). Spontaneous 
preterm delivery (4.9% vs. 1.6%, p = 0.003), 
medical induction of  delivery (27.7% vs. 18.5%, 
p = 0.01), vacuum extractions (10.2% vs. 4.9%, p 
= 0.02) and Caesarean sections (26.2% vs. 19.1%, 
p = 0.02) were more common to the ART group 
than to the control group. The mean (± SD) 
duration of  pregnancy at birth was shorter (39.6 
± 1.7 vs. 39.9 ± 1.4 weeks, p = 0.01) and the 
mean birth weight lower (3490 ± 554 vs. 3630 
± 500 g, p = 0.001) in the ART group than in 
the control group. These differences remained 
similar even if  only the eSET subgroup was 
compared with the control group. The frequency 
of  preterm births (7.4% vs. 3.9%, p = 0.07) and 
LBW infants (4.0% vs. 1.3%, p = 0.06) tended 
to be higher in the ART than in the control 
group. Nevertheless, no difference in the NICU 
admissions (3.7% vs. 1.6%, p = 0.11) or in the 
PNMR (8‰ vs. 3‰, p = 0.63) between the ART 
and the control group existed. 
The impact of  aetiology and duration 
of  infertility, number of  previous ART cycles 
and the current treatment type on the risks of  
preterm birth and LBW were evaluated in age- 
and BMI-adjusted multiple logistic regression 
analysis (Table 6). None of  the infertility- and 
treatment-related patient characteristics played 
an independent role in the risks of  preterm 
birth or LBW. However, a history of  induced 
abortion increased the risk of  preterm birth 
(OR 4.5; 95% CI 1.2–17.1).
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Table 6. Age- and BMI-adjusted multiple logistic regression. Odds ratios (ORs) and 95% 
confi dence intervals (CIs) for preterm birth and low birth weight in the ART singletons are shown. 
Preterm birth (< h 37 ) Low birth weight (< 2500 g)
n OR 95% CI n OR 95% CI
Total 309 310
Previous non-viable pregnancies
None* 193 1 - 193 1 -
Miscarriage 61 2.8 0.9-8.9 61 1.7 0.3-8.8
Induced abortion 29 4.5 1.2-17.1 29 3.3 0.6-19.2
Ectopic pregnancy 26 2.7 0.6-11.2 26 2.7 0.4-16.8
Nulliparity 218 0.9 0.3-2.3 219 1.4 0.3-6.2
Aetiology of  infertility
Female* 91 1 - 91 1 -
Male 84 0.3 0.1-1.5 84 1.0 0.1-7.3
Combined 60 0.8 0.2-3.0 60 2.1 0.3-12.3
Unexplained 74 0.8 0.2-3.0 75 1.2 0.2-7.9
Duration of  infertility (years)
< 2* 143 1 - 143 1 -
2-5 55 0.0 0.0- 56 0.0 0.0-
> 5 111 0.7 0.2-2.0 111 1.4 0.4-5.4
Number of  treatments
1-2* 161 1 - 162 1 -
3-4 83 0.5 0.1-1.6 83 0.2 0.0-1.7
≥5 65 1.1 0.3-3.0 56 0.6 0.1-3.7
Treatment type
IVF* 120 1 - 121 1 -
ICSI 56 1.6 0.4-5.7 56 0.6 0.1-7.2
FET 133 0.5 0.2-1.6 133 1.6 0.4-7.1
h = gestational weeks
* = reference group
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Number of  transferred embryos and 
obstetric and neonatal outcome (III)
The mothers in the SET group were younger 
than the mothers in the DET group but older 
than the control mothers (Table 4; p < 0.001). 
The SES of  the mothers and the proportion of  
nulliparous women were similar in the SET and 
DET groups. In comparison with the controls, 
SET mothers were of  higher SES, smoked 
less frequently during the pregnancy (10.0%
vs. 15.7%, p = 0.04) and were more often 
nulliparous (79.9% vs. 43.8%, p < 0.0001).
ART characteristics 
The frequencies of  the different infertility 
aetiologies and ART types did not differ between 
the SET and DET groups (Table 4). A total 
of  224 (83.3%) pregnancies in the SET group 
followed eSET. Twenty-fi ve (10.9%) out of  the 
230 pregnancies in the DET group originated 
from a vanishing twin pregnancy. Cessation of  
embryonal/foetal development was diagnosed 
by eight weeks of  gestation in 48% of  the 
cases.
Single embryo transfer versus double embryo
transfer
The prevalence of  maternal pregnancy 
complications and hospitalisation pre- and 
postpartum was equally common in the SET 
and DET groups. The proportions of  induced 
deliveries (13.8% vs. 18.7%, p = 0.13) and 
Caesarean sections (26.8% vs. 25.7%, p = 0.77) 
were comparable in the SET and DET groups. 
The mean gestational age at birth, mean birth 
weight, numbers of  SGA infants and NICU 
admissions, and the PNMR were alike in the 
SET and DET groups (Table 7). No difference 
in the prevalence of  major congenital anomalies 
between the SET (555/10 000) and DET groups 
(476/10 000) existed (p = 0.84).
Single embryo transfer versus spontaneous
conception
The age-, parity- and SES-adjusted risks of  
gestational hypertension (OR 2.35; 95% CI 
1.57–3.53), deep venous thrombosis (OR 
27.7; 1.49–513.8), maternal care because of  
congenital malformation of  the uterus (OR 
5.55; 1.14–27.0) and cervical incompetence (OR 
7.58; 2.81–21.9), placenta praevia (OR 4.75; 
2.57–8.78) and preterm contractions (OR 2.70; 
1.83–3.98) were increased in the SET mothers. 
Also, Caesarean sections (adjusted OR 1.54; 
1.18–2.00) and manual removal of  the placenta 
(adjusted OR 2.50; 1.50–4.16) were more typical 
of  the SET group than the control group. The 
mean gestational age at birth was less and the 
mean birth weight was lower in the SET than 
in the control group (Table 7). The age-, parity- 
and SES-adjusted risks of  preterm birth (OR 
2.58; 1.96–4.16), LBW (OR 2.01; 1.19–3.99) and 
low Apgar scores (OR 1.96; 1.01–3.04) were 
elevated in the SET group. 
When comparing the DET group with 
the control group, increased risks of  preterm 
birth (OR 2.63; 1.73–4.00), LBW (OR 3.46; 
2.20–5.46), low Apgar scores (OR 1.75; 1.01–
3.04) and NICU admission (OR 2.23; 1.08–4.58) 
were observed.
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Table 7. Neonatal outcome after SET, DET and spontaneous conception.
SET DET Controls p p
SET 
vs. 
DET
SET 
vs. 
CONTROL
Total 269 230 15037
Gestational weeks at birth 
mean (SD) 38.7 (2.2) 38.7 (2.5) 39.4 (1.8) 1.00 <0.001
n (%) n (%) n (%)
≥ 37 236 (87.7) 204 (88.7) 14302 (95.1)
}0.90 }<0.00132–36 30 (11.2) 23 (10.0) 558 (3.7)
< 32 3 (1.1) 3 (1.3) 108 (0.7)
Birth weight (g)
mean (SD) 3364 (621) 3340 (668) 3541 (547) 0.34 <0.001
n (%) n (%) n (%)
≥ 2500  253 (94.1) 208 (90.4) 14554 (96.8)
}0.16 }0.041500–2499 12 (4.5) 20 (8.7) 355 (2.4)
< 1500 3 (1.1) 2 (0.9) 86 (0.6)
n (%) n (%) n (%)
SGA 10 (3.7) 10 (4.4) 314 (2.1) 0.72 0.07
Apgar scores 0–6 at 1 min 16 (5.9) 14 (6.1) 555 (3.7) 0.95 0.05
NICU admission 8 (3.0) 8 (3.5) 227 (1.5) 0.75 0.07
PNMR (all) 3 (1.1) 3 (1.3) 68 (0.45) 0.85 0.11
Stillbirths 3 (1.1) 2 (0.9) 47 (0.31) 0.78 0.02
Neonatal deaths 0 1 (0.4) 21 (0.14) 0.28 0.54
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Fear-of-childbirth and pregnancy-
related anxiety (IV)
The mean (± SD) age of  the participants was 
similar in the ART and control groups (Table 
4; p = 0.18). Nulliparity was more typical of  the 
ART mothers than the controls (Table 4; p < 
0.001). The duration of  partnership (mean ± 
SD) was longer in the ART than in the control 
group (9.7 ± 4.4 vs. 7.7 ± 4.4 years, p < 0.001). 
ART versus control group
The median scores in the rFDQ (2.0) and 
PAS (20.0) were similar in the two groups.
No differences in the median scores of  
pregnancy-, delivery- and hospitalisation-specifi c 
PAS questions existed. Also, severe fear-of-
childbirth and pregnancy-related anxiety was 
equally common to the ART and the control 
groups (Table 8). According to the results of  
adjusted multiple logistic regression analysis 
in nulliparous participants, partnership of  fi ve 
years or more protected women from severe 
fear of  childbirth (OR 0.3; 0.2–0.7), whereas 
maternal age, education, previous nonviable 
pregnancies or somatic problems in the present 
pregnancy did not contribute to the risk of  
either severe fear-of-childbirth or pregnancy-
related anxiety. 
Nulliparous versus parous participants
Severe fear-of-childbirth was more frequent 
among the nulliparous women than among 
the parous women (13.4% vs. 8.3%, p = 0.03). 
Also, severe pregnancy-related anxiety was more 
typical of  nulliparous than parous participants 
(14.4% vs. 7.7%, p = 0.004). However, when 
comparing the impact of  parity separately in the 
ART and control groups, only the nulliparous 
control women showed severe pregnancy-
related anxiety more frequently than the parous 
controls (Table 8). 
Impact of  infertility and treatment-related 
characteristics 
The aetiology or treatment type did not 
infl uence the risks of  severe fear-of-childbirth 
or pregnancy-related anxiety. A long period of  
infertility (seven or more years) increased the 
risk of  severe fear-of-childbirth (OR 4.4; 1.2–
16.9), whereas more than four previous IVF 
treatments decreased the risk of  severe fear-of-
childbirth (OR 0.06; 0.005–0.7).
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Table 8. Prevalence of  severe fear-of-childbirth and pregnancy-related anxiety (total scores equal to 
or more than the 90th percentile in rFDQ or in PAS) according to group and parity.
Group
ART CONTROL p
n (%) n (%)
Total 367 379
rFDQ 42 (11.4) 40 (10.6) 0.56
PAS 46 (12.5) 38 (10.0) 0.16
Nulliparous 260 135
rFDQ 34 (13.1) 19 (14.1) 1.00
PAS 37 (14.2) 20 (14.8)* 1.00
Parous 107 244
rFDQ 8 (7.5) 21 (8.6) 1.00
PAS 9 (8.4) 18 (7.4)* 0.51
* = p < 0.05 between the nulliparous and parous participants in the control group 
PAS = pregnancy anxiety scale
rFDQ = revised version of   the fear-of-childbirth  questionnaire
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DISCUSSION
Assisted reproductive treatment has proven an 
effi cient treatment for infertile couples since 
its introduction in 1978. The numbers of  
initiated cycles and children born is still on the 
increase in Finland (STAKES 2006), in Europe 
as a whole (The European IVF-monitoring 
programme (EIM) 2006) and in other parts 
of  the world (International Committee for 
Monitoring Assisted Reproductive Technology 
2006). Although ART is effi cient it entails 
increased risks of  ectopic pregnancy, certain 
obstetric complications, operative delivery and 
preterm birth, even in singleton gestations. 
These elevated risks may all be of  signifi cance 
as regards the short- and long-term somatic 
and mental health of  women, their infants and 
the family. Therefore, better understanding of  
the possible underlying mechanisms behind the 
elevated risks is important. 
The aim of  the present study was to 
evaluate the associations between infertility- 
and treatment-related characteristics and early 
pregnancy monitoring, obstetric and neonatal 
outcome and prevalence of  fear-of-childbirth 
and pregnancy-related anxiety in singleton 
pregnancies after ART. These associations 
were studied among representative samples of  
women receiving ART: the response rate was 
nearly ninety per cent as regards the longitudinal 
material (II, IV) and whole patient cohorts 
were used in the cross-sectional studies (I, 
III). The aetiological and treatment subgroups 
in the study’s ART group correspond well 
to the nationally reported distribution of  
aetiological and treatment subgroups (Gissler 
and Tiitinen 2001; STAKES 2006). The used 
data was collected both prospectively from 
a longitudinal, self-reported questionnaire 
survey (II, IV) and retrospectively from patient- 
and national health registers (I, III). These 
approaches to obtain data complement one 
another. Although the information provided 
by the national health registers is accurate and 
the coverage is nearly 100%, individual patient 
and treatment characteristics are not recorded 
in these registers. Further, evaluation of  the 
psychological aspects of  pregnancy – such 
as the prevalence of  fear-of-childbirth and 
pregnancy-related anxiety after ART – requires 
sensitive and valid assessment tools not present 
as part of  the patient records.
The use of  self-reported data is suitable 
for the assessment of  subjective well-being. 
Subjective interpretation of  one’s health may be of  
more importance to an individual’s psychological 
well-being than objectively measured health. 
On the other hand, self-reported perception 
of  the somatic course of  pregnancy (although 
interpreted via structured questions) may differ 
from the perception of  medical professionals 
and should therefore be interpreted carefully. 
The most critical neonatal outcome measures 
(gestational age at birth and birth weight) in 
Study II were also checked from the clinics’ 
patient records.
The limitation of  these studies is in the 
statistical power. Although the sample sizes can 
be considered suffi cient for fi nding differences in 
various comparisons, much larger samples would 
have been needed to confi rm non-signifi cant 
fi ndings with high power. However, because two 
of  these studies (II, III) are concerned with a 
relatively new ART option – i.e. eSET – much 
larger samples were not achievable within the 
study period. 
The predictive value of  single hCG 
measurement 
In line with earlier results, women with viable 
pregnancies had signifi cantly higher median 
serum hCG levels than those with non-viable 
pregnancies (Schmidt et al. 1994; Bjercke et al. 
1999; Sugantha et al. 2000). The chosen cut-
off  level of  hCG (76 IU/L) assessed 12 days 
after ET predicted viable pregnancies with 80% 
sensitivity, 82% specifi city, and had 87% PPV 
and 74% NPV. These fi gures mean that 87% of  
women whose serum hCG concentration was 76 
IU/L or higher had a viable pregnancy, whereas 
74% of  women with an hCG level under 76 IU/
L had a non-viable pregnancy. The cut-off  level 
for prediction of  pregnancy outcome is always a 
compromise between sensitivity and specifi city. 
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Both lower and higher cut-off  levels than ours 
have been suggested (Okamoto et al. 1987; 
Fridström et al. 1995; Sugantha et al. 2000). The 
heterogeneity of  results in respect to the cut-off  
levels could be a consequence of  differences in 
hCG assays, assessment times and defi nitions 
of  viable and non-viable pregnancies between 
the various studies. Therefore, every infertility 
clinic should preferably defi ne the optimal hCG 
cut-off  level to use as regards their individual 
setting.
The most valuable information as 
regards hCG was that a single serum hCG level 
determination appears to suit all viable singleton 
pregnancies irrespective of  aetiological and 
treatment subgroups. The observed similar 
median hCG levels in singleton pregnancies 
achieved by means of  single embryo transfer 
and double embryo transfer is also of  clinical 
importance. Nearly 50% of  Finnish embryo 
transfers are currently performed with SET, but 
hCG values in singleton pregnancies following 
SET had not been published before this study. In 
2004, single hCG measurement was confi rmed 
as a valuable tool in pregnancies following SET 
(De Neubourg et al. 2004). The estimated ten 
per cent cohort of  vanishing twin pregnancies 
after DET might be associated with higher 
initial hCG levels than in singleton pregnancies 
achieved with SET. Although this assumption 
has not been confi rmed by early hCG assay, 
higher hCG-β values later in the fi rst trimester 
in vanishing twin pregnancies than in singleton 
pregnancies have been noticed (Chasen et al. 
2006b). Probably, the effect of  the number of  
transferred embryos on initial hCG rise should 
be studied in larger samples.
The lowest hCG value among viable 
singleton pregnancies was observed in the 
male factor subgroup, treated by means of  
ICSI. However, hCG levels in the viable 
singleton pregnancies in this subgroup were 
above the chosen cut-off  level, suggesting 
that misclassifi cation of  these pregnancies to 
non-viable pregnancies is unlikely. Lower hCG 
levels after ICSI than after IVF have also been 
reported before (Gold et al. 2000). The reason 
for a lower initial hCG concentration could 
be related to later implantation and different 
trophoblast invasion after ICSI than after IVF. 
However, in ICSI many steps of  fertilization are 
by-passed and embryonic development together 
with the hCG rise might be expected to begin 
earlier rather than later compared with IVF.
Early recognition of  an ectopic pregnancy 
offers a clinical challenge. In our sample most 
women with ectopic pregnancies (i.e. 19 out of  
20) had an hCG level lower than 66 IU/L. As 
miscarriages and biochemical pregnancies are 
characterised by hCG levels similar to those 
observed in ectopic pregnancies, repetitive 
sampling is advisable. Repetitive sampling is 
especially advisable for patients with low serum 
hCG concentrations and underlying tubal factor 
infertility.
We found no association between serum 
hCG levels 12 days after ET and adjusted birth 
weight of  singleton infants. As desirable as an 
early biochemical marker for the evaluation of  
successful placentation and neonatal outcome 
may be, placentation is far too complicated a 
process to be predicted by means of  a single 
biomarker.
Impact of  infertility- and treatment-
related factors on obstetric and 
neonatal outcome     
The association between a prolonged time 
to achieve a pregnancy and increased risks of  
preterm birth, LBW and neonatal mortality is 
well documented (Henriksen et al. 1997; Basso 
and Baird 2003; Basso and Olsen 2005). The 
impact of  duration of  infertility preceding 
successful ART ,however, has not been studied. 
In this study we classifi ed the duration of  
infertility into three subgroups (less than two 
years, two to fi ve years and over fi ve years) 
and analysed its contribution to neonatal risks. 
No association between increasing duration 
of  infertility and risk of  preterm birth or 
LBW was observed. This observation may be 
confounded by the fact that the women with 
the worst prognosis and longest duration of  
infertility might have dropped out because of  
total fertilization failure or a low number of  
retrieved oocytes. Furthermore, the duration 
of  infertility is correlated to female age. As the 
participants in this study were 40 years of  age at 
46
most, evaluation of  the impact of  the duration 
of  infertility on adverse neonatal outcomes may 
be limited. The number of  preceding treatments 
did not contribute to the risk of  preterm birth 
or LBW either.
The aetiological and treatment subgroups 
did not differ in respect to the risks of  preterm 
birth and LBW. In larger samples signifi cantly 
decreased risks of  preterm birth and LBW after 
singleton ART gestation in couples with male 
factor versus female factor infertility and after 
frozen versus fresh embryo transfer have been 
noticed (Schieve et al. 2004; Källén et al. 2005b; 
Wang et al. 2005). The lower risks of  preterm 
birth and LBW in cases of  male factor infertility 
probably refl ect normal female fecundity. The 
lower risks of  preterm birth and LBW after 
frozen embryo transfer might also in part refl ect 
only moderately impaired fertility of  these 
couples, as conception rates are generally lower 
after FET than after fresh embryo transfer. 
Further, hormonal stimulation is considerably 
more “gentle” in FET cycles than in fresh 
embryo transfer cycles, which may be related to 
the decreased neonatal risks.
Even though high-risk patients are 
diffi cult to identify by means of  patient- and 
treatment-related factors, our results support 
the current treatment policy: Carrying out ART 
among women with a relatively long duration 
of  infertility, or with a history of  numerous 
previous ART cycles, does not increase the risk 
of  adverse neonatal outcomes.
The only identifi ed risk factor for preterm 
birth among the background characteristics of  
women conceiving after ART was a history 
of  previous induced abortion. A history of  
previous induced abortion has been considered 
a risk factor for subsequent preterm birth in an 
international multi-centre case-control study 
(Ancel et al. 2004). Whereas a history of  a single 
induced abortion is not considered to increase 
the risk of  preterm birth, multiple induced 
abortions may predispose a woman to preterm 
birth via destruction of  the cervical canal and 
endometrium. In the present analysis a history 
of  induced abortion was coded dichotomously 
(no induced abortion or one/more induced 
abortion) and therefore the inclusion of  possible 
repetitive induced abortions as an explanation 
for the observed increased risk of  preterm birth 
cannot be excluded. However, because a history 
of  induced abortion is present in a minority of  
women undergoing ART (9% in our sample), 
the absolute increase in preterm births as a 
result of  previous induced abortion is probably 
small. 
Number of  transferred embryos
If  an active single embryo transfer policy is 
not adhered to, approximately 90% of  embryo 
transfers are carried out with replacement of  
two or more embryos into the uterine cavity. 
Apart from the high (25–30%) twinning rate and 
associated obstetric and neonatal complications, 
DET can have a negative infl uence on singleton 
outcomes via the worse neonatal outcome of  
vanishing twin survivors.
Our hypothesis was that obstetric and 
neonatal outcome of  singleton pregnancies 
following SET would be better than that of  
singleton pregnancies following DET. However, 
we did not fi nd differences in obstetric and 
neonatal outcome between SET and DET 
groups in our seven-year cohort. In addition, 
in age-, parity- and SES-adjusted comparison 
with spontaneously conceiving controls the 
SET group had increased risks of  gestational 
hypertension, preterm contractions, placenta 
praevia, Caesarean section, preterm birth and 
LBW. Similarly, increased risks of  preterm birth 
and LBW were also observed when adjusted 
comparisons between the DET and the 
spontaneously conceiving control group were 
carried out.
The results of  many observational and 
register-based studies have confi rmed more 
frequent pregnancy-induced hypertension, 
placenta praevia and Caesarean section in 
singleton pregnancies after ART than after 
spontaneous conception (Jackson et al. 2004). 
Here, these risks were also observed in singleton 
pregnancies following SET. The results remained 
essentially same even if  only pregnancies 
following eSET were analysed. Our results imply 
that the vanishing twin phenomenon is not the 
only mechanism behind these increased risks. 
Further, the similar obstetric risk after transfer 
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of  good quality embryos in eSET cycles (i.e. 
embryos with less than 20% fragmentation and 
without multinucleated blastomeres) suggests 
that other patient- and probably female-related 
reasons for increased obstetric risks exist in 
the ART population. One possible mechanism 
behind more frequent hypertensive disorders 
and placenta praevia after ART may be abnormal 
placentation, which on the other hand can be 
related to hormonal stimulation, embryo culture 
and the embryo transfer technique rather than 
to the number of  transferred embryos. The 
increased risk of  emergency Caesarean sections 
after SET is probably explained by the more 
frequent obstetric complications. 
Very few studies have addressed the 
impact of  the number of  transferred embryos 
on singleton outcomes after ART (De Sutter 
et al. 2003; De Neubourg et al. 2006; De Sutter 
et al. 2006b; Kjellberg et al. 2006). Inclusion 
of  only good-prognosis patients (i.e. women 
aged less than 35–37 years, having their fi rst or 
second treatment cycle, and receiving a good-
quality embryo) is typical of  other SET studies. 
In contrast, in our sample, SET was initially 
carried out among women with known obstetric 
risks (Vilska et al. 1999). For the last three study 
years SET has been the preferred treatment 
in the majority of  cases and DET took place 
only if  no special contraindication for a twin 
pregnancy was recognised, the couple had gone 
through two unsuccessful IVF cycles, or only 
poor quality embryos were obtained (Tiitinen et 
al. 2003).
Despite the differences in patient 
characteristics between previously published 
studies and this study, the mean gestational 
age at birth and the mean birth weight in our 
SET sample were similar to those reported 
before in observational studies (De Sutter et 
al. 2003; De Neubourg et al. 2006). In contrast, 
the duration of  pregnancy was longer and 
the mean birth weight was higher in the SET 
singletons in a randomized study (Kjellberg et 
al. 2006) than in our study. The observed rate 
of  preterm births (12.3%) in our sample was 
higher than that in the other SET studies (6.2% 
to 11.6%) (De Neubourg et al. 2006; De Sutter 
et al. 2006b; Kjellberg et al. 2006). This probably 
refl ects the inclusion of  women with congenital 
malformation of  the uterus and a history of  
cervical incompetence in our sample. On the 
other hand, the rate of  preterm births in our 
study is similar to that of  8–14% in national 
and international register-based studies which 
do not take the number of  transferred embryos 
into account (Klemetti et al. 2002; Schieve et al. 
2004; Källén et al. 2005a).
The increased risks of  LBW and low 
Apgar scores in our SET sample compared with 
the controls refl ects the higher incidence of  
preterm births. The non-signifi cantly increased 
risk of  SGA, on the other hand, implies that 
the shorter duration of  pregnancy rather than 
growth retardation results in a lower birth 
weight. We could not compare the incidence 
of  congenital anomalies between the SET and 
the control group. However, the observed 
incidence of  congenital anomalies after SET 
seemed similar to that in a larger cohort of  
Finnish infants after ART and higher than in 
spontaneously conceived infants (Klemetti et al. 
2005). 
Prevalence and predicting factors of
fear-of-childbirth and pregnancy-
related anxiety
In contrast to our expectations we found a 
similar prevalence of  severe fear-of-childbirth 
and pregnancy-related anxiety in the ART and 
control groups in our study. This opposes the 
hypothesis that the psychologically demanding 
treatment of  infertility and possible cumulative 
disappointments after unsuccessful treatment 
cycles would increase formerly infertile women’s 
vulnerability to the emotional demands of  
pregnancy. Our fi nding further disagrees with 
previous results suggesting more pronounced 
pregnancy-specifi c anxiety after ART (McMahon 
et al. 1997; Hjelmstedt et al. 2003).
The observed similar prevalence of  
severe fear-of-childbirth and pregnancy-related 
anxiety may be a result of  selection of  patients 
with good psychological coping strategies and 
satisfactory relationships in our ART group. 
Generally, couples seeking infertility treatment 
do not have an excess of  psychological disorders. 
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However, unsuccessful ART enhances levels of  
anxiety and depression (Newton et al. 1990; 
Verhaak et al. 2005). The psychological demands 
of  repeated ART after previous failure represent 
a common reason for discontinuing further 
treatment (Olivius et al. 2004). Therefore, the 
decision to continue ART despite unsuccessful 
treatment can be a sign of  well-functioning 
coping strategies and adequate social support 
from the spouse (Peterson et al. 2003; Schmidt 
et al. 2005) or other social network. Interestingly, 
for women, an increasing number of  previous 
unsuccessful treatment attempts correlates with 
good marital satisfaction, even during the child’s 
fi rst year of  life (Repokari et al., in pressa). In our 
sample, 70% of  the participants had a history of  
previous ART attempts. 
Several investigators have shown 
that after successful ART the prevalence of  
depression in women is similar to (Reading et al. 
1989; Gibson et al. 2000; Klock and Greenfeld 
2000) or less than (Repokari et al. 2005) that 
in controls. Levels of  general anxiety decrease 
after successful ART (Verhaak et al. 2005) and 
come close to the norm (Repokari et al. 2005). 
The data suggest that the negative emotional 
burden of  ART primarily results from the threat 
of  remaining childless and it is not because of  
the ART method itself. In addition, the results 
of  short- and long-term longitudinal studies on 
parenthood after ART indicate that there is no 
excess of  parenting stress or mental problems 
in formerly infertile couples (Abbey et al. 1992; 
Gibson et al. 2000; Greenfeld and Caruso Klock 
2001; Colpin and Soenen 2002; Repokari et al. 
2005). Instead, ART mothers tend to experience 
motherhood more positively than spontaneously 
conceiving mothers regardless of  more frequent 
obstetric and neonatal complications (Repokari 
et al. in pressb). In conclusion, couples who 
conceive after ART are probably psychologically 
well-adjusted for the new emotional demands 
of  parenthood. Against this background our 
result of  similar prevalence of  severe fear-of-
childbirth in the ART and control groups is not 
surprising.
We tried to identify the predictive factors 
of  severe fear-of-childbirth and pregnancy-
related anxiety in nulliparous women. We decided 
to limit the multiple logistic regression analysis to 
nulliparous women, as we were unable to control 
for the impact of  previous delivery. We restricted 
the evaluation of  predictive factors of  severe 
fear-of-childbirth and pregnancy-related anxiety 
to demographic-, obstetric- and infertility-
related factors. This decision is justifi ed, as 
these factors are easily assessable during clinical 
follow-up. Identifi cation of  a patient group at 
an increased risk, using such factors, would be 
of  clinical use. In contrast to earlier studies, 
neither somatic symptoms such as hyperemesis 
(Swallow et al. 2004), nor previous non-viable 
pregnancy (Saisto et al. 1999) infl uenced the 
risk of  severe fear-of-childbirth. Instead, a 
fi ve- to ten-year partnership protected women 
from severe fear-of-childbirth. Previously, 
dissatisfaction with the partnership has been 
verifi ed among the most signifi cant predictors 
of  fear-of-childbirth (Saisto et al. 2001a). It is 
diffi cult to say whether a long partnership is 
also a satisfactory one, but the protective role 
of  a fi ve- to ten-year partnership could be 
mediated through partnership satisfaction. The 
observed protective role of  a relatively long 
partnership could also explain the less evident 
impact of  parity on severe fear-of-childbirth 
and pregnancy-related anxiety in the ART group 
than in the control group, as the partnerships 
of  both the nulliparous and parous participants 
had lasted longer in the ART group than in the 
control group. 
We did not study simultaneous prevalence 
of  depression and general anxiety in association 
with fear-of-childbirth and pregnancy-related 
anxiety. However, mental health was compared 
between the groups separately (Repokari et al. 
2005). The women in the ART group had fewer 
depressive symptoms but equal levels of  general 
anxiety compared with the control women at 
the time when fear-of-childbirth and pregnancy-
related anxiety were assessed (i.e. gestational 
week 20). Because underlying anxiety rather 
than depression is an independent psychological 
predictor of  fear-of-childbirth (Saisto et al. 
2001a), the difference in level of  depression 
does not explain the similarly expressed fear-
of-childbirth in the groups. More frequent 
depression could, on the other hand, predispose 
the control women to more frequent pregnancy-
related anxiety (Saisto et al. 2001a). However, 
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women expecting their fi rst child were less 
depressed than the parous participants, although 
they reported severe pregnancy-related anxiety 
more frequently. 
Among infertility- and treatment-related 
characteristics only a long duration of  preceding 
infertility (seven or more years) increased the risk 
of  severe fear-of-childbirth. Even though this 
fi nding is based on a relatively small subgroup 
of  patients it fi ts our original hypothesis well. 
Women with a long duration of  infertility may 
be especially vulnerable to the potential threat of  
losing the pregnancy or the infant, which could 
be expressed as intense fear-of-childbirth. 
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SUMMARY AND CONCLUSIONS
The aim of  this study was to evaluate the impact 
of  infertility- and treatment-related factors on 
prediction of  pregnancy outcome, obstetric and 
neonatal risks and experience of  pregnancy in 
singleton pregnancy after ART.  
Our results indicate that single serum 
hCG sampling as early as 12 days after embryo 
transfer is a reliable tool for predicting viable 
pregnancy. The aetiology of  infertility, treatment 
type or the number of  transferred embryos did 
not affect the predictive value of  the serum 
concentration of  hCG. If  a woman with tubal 
factor infertility has a serum hCG level below 
the suggested cut-off  level, repetitive hCG 
sampling is advisable. Our fi ndings help in 
follow-up of  early pregnancy and may relieve the 
psychological distress related to the uncertainty 
of  pregnancy outcome experienced by couples 
undergoing ART.
The risks of  preterm birth and LBW 
were increased in singleton ART pregnancies 
regardless of  the aetiology of  infertility or 
treatment type. In addition, the risks of  preterm 
birth and LBW remained elevated compared 
with those in the controls in our preliminary 
cohort of  singleton ART pregnancies achieved 
after SET. This suggests that even the most 
preferable treatment procedure – SET – does 
not moderate all the commonly recognised 
risks associated with ART. Nevertheless, SET is 
defi nitely a better treatment for a woman with 
obstetric risks than DET. Larger samples with 
different subject characteristics will probably 
complement our results.
The similar prevalence of  fear-of-
childbirth and pregnancy-related anxiety in the 
ART group compared with the spontaneously 
conceiving controls is a relieving fi nding. It 
implies that after successful ART previous 
infertility does not have a long-standing negative 
effect on a woman’s psychological well-being. It 
further implies that fear-of-childbirth can hardly 
be an explanation for more common Caesarean 
sections in singleton ART gestations. Altogether, 
the similar prevalence of  fear-of-childbirth and 
pregnancy-related anxiety suggests that women 
conceiving by means of  ART are psychologically 
well adjusted and they probably receive adequate 
support from their partners. Nevertheless, 
women with a long duration of  preceding 
infertility seem to be at an increased risk of  
fear-of-childbirth and may need psychosocial 
support during the pregnancy. The challenge 
for infertility professionals and obstetricians 
remains to recognise and respond to patients’ 
needs on an individual basis.
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APPENDIX
Table 9. Contents of  the revised version of  the Fear-of-Childbirth Questionnaire (modifi ed from 
Saisto et al. 2001b).
 1. Do you have diffi culties relaxing because you are thinking of  the delivery?
 2. Are you afraid of  being seized with panic at the delivery?
 3. Are you afraid that the nurses won’t take care of  you during the delivery?
 4. Have you always been afraid of  giving birth?
 5. Are you afraid that the baby will not be healthy? 
 6. Have you had nightmares about the delivery?
 7. Are you afraid of  rupturing during the delivery?
 8. Are you afraid of  painful injections during the delivery?
 9. Are you afraid of  losing control of  yourself  at the delivery?
10. Do you prefer Caesarean section to an ordinary delivery?
11. Are you afraid of  death when thinking of  the delivery? 
each question was asked to be answered dichotomously (i.e. either yes=1 or no=0)
Table 10. Contents of  the Pregnancy Anxiety Scale (Saisto et al. 2001b).
 1. Has anyone frightened you about having a baby?
 2. Have you read anything that frightened you about having a baby?
 3. Do you fear that you will fall and hurt your baby?
 4. Are you afraid of  the labour pain?
 5. Are you going to ask for pain medicine in delivery?
 6. Do you fear about being cut when the baby is born?
 7. Are you afraid your baby would not be normal?
 8. Are you afraid you will be alone in the hospital?
 9. Are you worried that the doctors may not be friendly?
10. Are you worried that the nurses may not be friendly?
each question was asked to be answered on fi ve-point scale (i.e. not at all=1, little=2, some=3, 
yes=4, a lot =5)
